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ABSTRACT 
Oental stem cells (OSCs) have been identified in teeth and their supporting tissues. They 
represent an exclusive source of adult stem cells, easily isolated and manipulated for tissue 
repair and regeneration. This research project evaluated the neurogenic potential of the 
dental pulp stem cells (OPSCs) and stem cells from the pulp of human exfoliated 
deciduous teeth (SHEDs) in a South African cohort. 
Sixty non-carious permanent and deciduous teeth were extracted from healthy patients 
aged between 18 and 30 years and 5 and 10 years, at the University of the Witwatersrand's 
Oral Health Clinic in Johannesburg Charlotte Maxeke Academic Hospital, South Africa. 
The cells, isolated from the extracted pulp tissue were cultured, counted and then 
phenotyped by flow cytometry analysis. The cells were further expanded in a neural 
induction medium and immunocytochemistry analysis for Ki-67, doublecortin (DCX) and 
nestin were performed. 
Large colonies of both DPSCs and SHEDS were harvested from the extracted pulp tissues 
and positively cultured. Flow cytometry analysis confirmed the presence of CD44+ and 
CD29+ cells as well as the known mesenchymal stem cell markers CD90 and C0105. Both 
DPSCs and SHEDs demonstrated successful proliferation and neural differentiation. This 
study confirmed that DPSCs and SHEDs are highly proliferative human adult stem cells 
that exhibit a neurogenic potential that may contribute in the treatment of neurological 
disorders. 
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INTRODUCTION 
1.1. Background to the study 
1.1.1. Stem cells 
CHAPTER 1 
Stem cells are defined by two fundamental criteria, the ability of continuous self-renewal 
through indefinite mitotic division and the capacity to give rise to specialised cell lineages. 
They are primarily classified into embryonic or adult/postnatal type (Minguel et al. 2001). 
During the past decades, stem cells have been extensively explored and their unique 
biological properties have generated a great amount of interest for therapeutic use in the field 
of regenerative medicine (Caplan 2005). 
1.1.1.1. Embryonic stem cells 
Embryonic stem cells are derived from the embryo and they consist of the morula's 
totipotent cells in early intrauterine I ife. They are therefore capable of reproducing all cell 
types of the three germ layers of the embryo, including extra-embryonic structures such as 
the placenta (Mummery et al. 2010). They are also capable of propagating indefinitely in 
an undifferentiated state (Vazin et al. 2010). However, this totipotency persists in the 
embryo for approximately four days only after fertilisation. As differentiation proceeds 
and the fertilised egg is gradually implanted into the endometrium of the uterine wall, the 
totipotent cells are replaced by the inner mass cells of the blastocyst that have lost their 
competence to give rise to an entire organism and evolve into pluripotent cells: although 
they retain the potential to develop into all tissues of the embryo and the adult, they are no 
longer able to form extra-embryonic structures. Later in development, the stem cells in the 
foetus become multipotent and are able to give rise to all cell lineages. 
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1.1.1.2. Adult stem cells 
Properties of adult stem cells 
Adult stem cells exhibit a lower regeneration potential. They are multi potent, or unipotent 
when they differentiate into one cell type only, and they have been isolated from the 
umbilical cord as well as numerous postnatal tissue including bone marrow, brain, skin, 
hair follicles, skeletal muscle, teeth and periodontium (Turksen et al. 2004). The most 
extensively studied and best known adult stem cell is the bone marrow stem cell (BMSC), 
in which we distinguish two categories: the haematopoietic stem cells (HSCs) that 
differentiate into blood cells, and the bone marrow stromal cells (BMSCs). The latter 
forms the supporting tissue of the haematopoietic stem cells and consists of a mixed 
population of mesenchymal stem cells (MSCs) that generate bone, cartilage, adipose and 
fibrous connective tissues, when they are grown in specific in vitro conditions (Colter et al. 
2000; Huang et al. 2009). Furthermore, various types of cells are observed in this 
heterogeneous population, with regard to the degree of cell differentiation (Gronthos et al. 
1999). In rodents, bone marrow stem cells have a neurogenic potential as they are able to 
differentiate into both astrocytes and neurons when transplanted into the mouse brain 
(Kopen et al. 1999). However, this neurogenic potential is weaker compared to that of the 
known neural stem cells in the human subgranular zone of the dentate gyrus of the 
hippocampus and the subventricular zone in the lateral ventricle (Song et al. 2007). 
Mesenchymal stem cells isolated from other sources constitute a good replacement to the 
bone marrow stem cells as they are obtained in an easier manner. Besides, they display 
similar morphologic and immunophenotypic characteristics and they tend to divide more 
rapidly and form more colonies (Bianco et al. 2001; Kern et al. 2006). They therefore 
represent a better alternative for many clinical applications. These cells maintain their 
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phenotype after each cell division. The cells further away from the inductive tissue retain 
their original stem cell properties. In contrast, those close to the inductive structure lose 
their competence and become fully differentiated (Mummery et al. 2010). 
Clinical applications and limitations of adult stem cells 
Adult stem cells are currently and successfully used as a source of specific cell types for 
regenerative tissue engineering approaches and clinical applications. A prominent clinical 
application in stem cells research has been bone marrow transplants (Jiang et al. 2002; Ide 
et al. 2010; Hunt 2011). However, the isolation of postnatal stem cells has limitations in 
many instances; especially with regard to collecting sufficient cells from each patient, as a 
result of variations in age, health condition and cell function. Furthermore, research on 
human mesenchymal stem cells and their isolation from postnatal organs raises sharp ethical, 
religious and political issues. Moreover, there are several difficult dilemmas, including 
consent of individuals to donate materials for research purposes. 
1.1.1.3. Dental stem cells 
Dental stem cells are mesenchymal stem cells that have been identified from the teeth and 
their supportive tissues or periodontium (Gronthos et al. 2000; Miura et al. 2003; Seo et al. 
2004; Morsczeck et al. 2005; Sonoyama et al. 2008). These cells are adult mesenchymal 
stem cells that exhibit lower regeneration potential than the bone marrow mesenchymal 
stem cells. However, they have the capacity to give rise to distinct cell lineages (Huang et 
al. 2009) and originate from specialised tissues in which continuous remodelling, as in 
bone, does not occur, thus their differentiation potential is therefore restricted. 
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Five types of dental stem cells (DSCs) have been identified and characterised from human 
teeth and their periodontium: the dental pulp stem cells (DPSCs), the stem cells from the 
pulp of human exfoliated deciduous teeth (SHEDs), the stem cells of the periodontal 
ligament (PDLSCs), the stem cells of the apical papilla (SCAP) and the stem cells of the 
human dental follicle (DFSCs) (Huang et al. 2009). The dental pulp stem cells (DPSCs) 
and the stem cells from the pulp of human exfoliated deciduous teeth (SHEDs) are derived 
from the dental pulp of the permanent and deciduous teeth respectively (Gronthos et al. 
2000; Miura et al. 2003). The periodontal ligament stem cells (PDLSCs) have been 
isolated from the periodontal ligament of permanent teeth (Seo et al. 2004). Stem cells of 
the apical papilla have been observed in the apical end ofthe dental papilla of the 
developing apex of the permanent teeth (Sonoyama et al. 2008). The dental follicle 
progenitor cells have been isolated from the dental follicles of impacted third molars 
(Morsczeck et al. 2005). 
1.2. Overall objectives of the study 
Most of the experiments in the literature have proven that the human dental stem cells, in 
addition to their odontogenic potential, demonstrate very broad differentiation capabilities. 
They are able to give rise to adipogenic, chondrogenic, osteogenic, myogenic and 
neurogenic cells. Furthermore, it has been established that dental stem cells display a 
specific profile of cluster of differentiation markers (CD) similar to those of mesenchymal 
stem cells. They positively follow the requirements decreed by the International Society 
for Cellular Therapy that unequivocally define the phenotype of mesenchymal stem cells: 
they must express the specific cluster of differentiation markers (CD) on their cell surface 
(CD73, CD90 and CDl05) and they must be deprived of the common haematopoietic 
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markers, CD14, CD45 and CD34 (Dominici et al. 2006; Karaoz et al. 2010; Azouna et al. 
2012). 
The potential of dental stem cells to differentiate into neurologic tissues in specific 
induction media has been thoroughly researched (Arthur et al. 2008; Ulmer et al. 2010). 
Several studies have been performed in the Asian and European populations and have 
reported the successful isolation, proliferation, characterisation as well as the 
neurodegenerative properties of dental stem cells when transplanted into the injured central 
nervous system of adult rats or mice (Arthur et al. 2008; Sakai et al. 2012). These cells 
then are a valuable source of adult stem cells for regenerative medicine as they are easily 
isolated in a non-invasive manner and easily manipulated to obtain various multipotent cell 
colonies. These colonies can later, not only regenerate or repair lost dental tissues, but also 
other cell lineages damaged by disease, especially neurogenic cells. 
Moreover, because of the contribution of the neural crest cells that originate from the 
neural tube prior to its closure (Baroffio et al. 1991; Le Douarin et al. 2012), the dental 
tissues-derived stem cells tend to exhibit characteristics similar to neural crest cells. 
Consequently, due to the high prevalence of neurological disorders and the difficulties to 
harvest neural stem cells from the brain, establishing the neurogenic differentiation of 
dental stem cells could form a credible basis for clinical application. 
This previous research supports the use of human dental stem cells as a unique source of 
clinical material for regeneration such as neuroregeneration therapies. Since no such study 
has been undertaken in South Africa, focusing on such a project will upgrade all 
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information on the tooth-derived cells and will significantly contribute to the future 
therapies for neurological disorders. 
1.3. Literature review 
1.3.1. Historical background of stem cells 
The term "stem cell" emerged in the late nineteen century, when several investigations on 
the evolutionary basis of all plants and animals were increasingly conducted; it became 
gradually established in the field of embryology and cytology, although with some 
discrepancies in its definition (Maehle, 2011). In the early twentieth century, the idea of 
stem cells appeared to become reinforced in the haematological research of Artur 
Pappenheim (1870-1916) with his hypothesis of the presence of a multipotent stem cell in 
different forms of leukaemia (Brown et al. 2006). 
However, the term "stem cell" was first considered for scientific use by the Russian 
histologist Alexander Maximow (1874-1928), at the congress of the Haematological 
Society in Berlin in 1909. He discovered the theory ofhaematopoiesis and proposed the 
notion of the origin and further differentiation ofthe various types of blood cells, from a 
common haematopoietic precursor, both during embryonic development and in the adult 
life of mammals (Konstantinov 2000). The existence ofhaematopoietic stem cells was 
formerly postulated and the "stem cell" name was then attributed to various cells that have 
the ability to differentiate into specific types of somatic or germ cells in the body 
(Konstantinov, 2000). Following this, several research projects were developed and many 
reports on the different properties of stem cells in embryology, haematology and histology 
were released. 
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1.3.2. Emergence of stem cell biology 
Before World War I, the pI uri potency of stem cells and germ cells was also gradually 
associated with the onset of neoplasms, and the theory of Julius Cohnheim (1839-1894) 
resurfaced. This theory was initially presented in 1877 and stated that, with a sufficient 
blood supply, stem cells could grow in an uncontrolled manner to form tumours and cancer 
(Cooper, 2009). In a sim ilar manner, Theodore Boveri (1862-1915) in 1914 postulated that 
the malignant transformation of a tumour was due to lack of expression of mechanisms 
normally present in cells (Harris 2008). In the same period, embryonic tissue isolation and 
culture was developed and increasingly studied outside the embryo, leading to the modern 
approach of stem cell research (Maienschein 2009). In the early 1960s McCulloch et al 
further contributed to modern stem cell research in examining the effects of radiation on 
haematopoiesis in the bone marrow and introduced the term "colony forming unit" (CFU) 
to describe cell colonies deriving from a single haematopoietic stem cell (Till et at. 1961; 
Becker et al. 1963). This experiment represented the first quantitative assay that was 
performed for blood stem cells. 
1.3.3. Experiments on stem cells 
Further studies based on Maximow's fundamental research on haematopoiesis were then 
conducted. In the 60s, Alexander Friedenstein (1924-1998) and his co-workers discovered 
in the bone marrow of rodents, the co-existence ofhaematopoietic and adult non-
haematopoietic cells. The function of the latter cells was initially defined as the supporting 
cells ofhaematopoiesis. However, further examinations revealed that they had a 
clonogenic potential and could also give rise to skeletal tissue derivatives namely, 
fibroblastic, reticular, adipocytic and osteogenic. They appeared to be a functionally 
distinct type of stem cells that occurred with the haematopoietic stem cells in the bone 
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marrow and were therefore labelled as the "bone marrow stromal stem cells" (BMSSCs) 
since they arise from the complex array of supporting structures in the bone marrow 
(Friedenstein et 01. 1968). 
In the 70s, Friedenstein demonstrated that these spindle-shaped precursors' cells were 
adherent to plastic culture dishes: they gathered in foci of two to four cells and, after a 
dormancy period of two to four days they became highly proliferative. As the daughter 
cells appeared to self-replicate from a single fibroblast-like cell, Friedenstein termed them 
the colony forming unit-fibroblast (CFU-F). He later established that when cultured in the 
appropriate conditions, the cells were able to regenerate the bone matrix and its micro-
environment (Friedenstein et 01. 1966; Friedenstein et 01. 1974) in vitro and in vivo after 
their re-transplantation into laboratory animals (Friedenstein et 01. 1980). 
Extending his initial work to human bone marrow, Friedenstein was later able to show that 
the percentage of floating haematopoietic cells (30%) was less important than that of the 
adherent bone marrow stromal stem cells (Frieden stein et al. 1976). In addition, these 
replicating colonies were maintained in the primary culture for two to three weeks 
(Frieden stein et 01. 1976). The type of differentiation that they underwent (fibroblasts, 
osteoblasts, chondroblasts, adipocytes or myoblasts) depended on the nature of the 
supplement added to the culture medium. For instance, in the presence of dexamethasone, 
1, 25-dihydroxyvitamin 03, or cytokines such as BMP-2, the osteogenic, chondrogenic 
and adipogenic differentiation prevailed. On the other hand, in response to 5-azacytidine 
and amphotericin B or amphotericin B alone, the preferential differentiation was towards 
the myoblasts (Friedenstein et 01. 1976; Owen et 01. 1988). In that same era, Friedenstein 
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isolated mesenchymal stem cells from the stroma ofthe spleen and thymus (Friedenstein et 
al. 1972). 
Later in 1991, Caplan and his co-workers showed that the transplantation of bone marrow 
in other anatomical sites of mice resulted not only in the elimination of the haematopoietic 
cells, but also the active division and differentiation of the stromal cells. This was 
followed by the development of ectopic bone and cartilage and he used the term "bone 
marrow mesenchymal stem cells" as the source of progenitor cells for mesenchymal tissues 
(Caplan 1991). He also confirmed that the precursor' cells isolated from the chick and the 
mice embryos preferentially exhibited chondrogenic or osteogenic potential, depending on 
the different culture conditions in vitro, which corroborated Friedenstein's findings 
(Caplan et al. 1991; Bruder et al. 1997). 
Many experiments were further conducted on the adult bone marrow mesenchymal stem 
cells and additional differentiation such as ligament, tendon and stroma were successfully 
achieved (Caplan 1991; Bergman 1995). The characterisation of the bone marrow 
mesenchymal stem cells was accomplished later by Pittenger and his co-workers (1999). 
Cells harvested from the bone marrow of the iliac crest were culture-expanded and 
phenotyped by their ability to proliferate, their consistent expression of specific cell 
surface proteins and their consistent differentiation into multiple mesenchymal lineages 
under specific in vitro conditions (Pittenger et al. 1999). 
Following these studies, mesenchymal stem cells were further isolated in a variety of 
sources other than the bone marrow; these included the placenta and the umbilical cord in 
the foetus and mainly periosteum, muscle, adipose tissue, hair follicles, brain and the 
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cornea stroma (Mareschi et al. 2001; Reynolds et af. 1992). Gronthos and his co-workers 
searched for mesenchymal stem cells in the human teeth and their supportive tissue and 
identified a population of multipotent stem cells. These cells displayed the same 
characteristics as the mesenchymal stem cells and were therefore labelled dental stem cells 
(DSCs) (Gronthos et af. 2000). 
1.3.4. Experiments on dental stem cells 
Recently, postnatal stem cells have been isolated from the teeth and their supporting 
tissues. Like the bone marrow stromal stem cells and mesenchymal stem cells from other 
sources, they are multipotent cells able to give rise to distinct cell lineages (Huang et af. 
2009) with, however, a restricted differentiation potential. Nevertheless, their discovery 
has brought a significant breakthrough in stem cell research and regenerative medicine. In 
order to ensure a successful use of dental tissues in tissue engineering, a sound 
understanding of tooth development and tooth structure is required. 
1.3.5. Tooth development 
Odontogenesis is determined in the embryo by a complex sequence of reciprocal 
inductions between the oral ectoderm and the neural crest-derived mesenchymal cells, 
which also contribute to craniofacial development. Tooth development begins in the fifth 
week of intrauterine life as a result of the reciprocal interactions between the oral ectoderm 
that will generate the enamel organ, and the underlying mesenchymal cells that will give 
rise to the dental papilla (Chiego 2014). In addition to these two categories of cells, the 
neural crest cells that originate from the neural tube prior to its closure, also contribute to 
tooth development (Baroffio et al. 1991; Le Douarin et af. 2012). The neural crest cells 
are arranged in a flattened irregular mass that will form several structures including the 
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ganglion cells, the neurolemma sheath ofthe peripheral nerves, the leptomeninges, the 
pigments cells, and the suprarenal medulla (Moore et al. 2013). In addition, the neural 
crest cells migrate into the craniofacial complex and teeth at an early stage of development 
and invade and expand the mesenchyme, thus later referred to as ectomesenchyme (Nanci 
2008). 
Each developing tooth grows as an anatomical distinct unit but the basic developmental 
process is similar for all teeth (Chiego 2014). The first sign of tooth formation is the 
thickening of the oral ectoderm into the primary epithelial band that will further develop 
into dental and vestibular laminae (Nanci 2008). The latter will evolve into the vestibule 
of the oral cavity in the adult, while each tooth germ will appear from the former through 
successive stages: the bud, cap and bell stages. The bud stage corresponds to the first 
incursion of the dental lamina into the underlying ectomesenchyme. During the cap stage, 
the dental lamina condenses and forms the enamel organ giving rise to enamel, while the 
ectomesenchymal cells converge into the dental papilla that will synthesize the dentine and 
pulp complex. Both the enamel organ and the dental papilla are surrounded by the dental 
follicle which will later generate the periodontium or supporting tissues ofthe tooth. In the 
bell stage, morphodifferentiation and histodifferentiation occur, resulting in the crown 
configuration and the hard tissues production (Fig. I). This is followed by the root and 
periodontium development in the late bell stage of odontogenesis. Subsequently, the 
completed tooth crown erupts into the oral cavity, and root formation and cementogenesis 
continue until a functional tooth and its supporting structures are fully developed (Nanci 
2008; Chiego 2014). Since the completion of tooth formation in all deciduous and 
permanent teeth continues in postnatal life, it becomes evident that diverse stem cell niches 
are still present in the human teeth and their supporting tissues. 
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Figure I: Representative diagrams of the stages of tooth development. 
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As mentioned previously, five types of human dental stem cells (DSCs) have been 
identified and characterised from human teeth and their supporting tissues: the dental pulp 
stem cells (DPSCs), the stem cells from the pulp of human exfoliated deciduous teeth 
(SHEDs), the stem cells of the periodontal ligament (PDLSCs), the stem cells of the apical 
papilla (SCAP) and the stem cells of the human dental follicle (DFSCs). 
The literature extensively discusses how these progenitor cells exhibit the characteristics of 
umbilical cord and postnatal mesenchymal stem cells. They have the potential for self-
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renewal and they demonstrate very broad differentiation capabilities. In addition to their 
odontogenic potential, they are able to give rise to adipogenic, chondrogenic, osteogenic, 
myogenic and neurogenic cells. It has also been found that they express specific 
mesenchymal stem cell markers or clusters of differentiation (CD) such as C073, C090, 
CD 105 and CD 146; on the other hand, they lack haematopoietic stem cells markers such as 
CD 14, C045 and C034 (Karaoz et at. 20 10; Azouna et al. 2012). Furthermore, because of 
the contribution of the neural crest cells that originate from the neural tube prior to its 
closure, the dental tissues-derived stem cells tend to exhibit characteristics similar to neural 
crest cells. They are therefore a useful alternative for cell replacement in the treatment of 
tissues known to contain neural stem cells. The first type ofOSCs was isolated from the 
dental pulp tissue and termed adult dental pulp stem cells (OPSCs) (Gronthos et a12000; 
Huang et aI2009). 
1.3.6.1. Dental pulp stem cells (DPSCs) 
The general structure of an adult tooth consists of both hard and soft tissues arranged in the 
crown and the root(s). The dental pulp is the only soft tissue in the tooth and it supports 
the dentine which forms the bulk of the tooth (Nanci 2008). It can be divided into two 
parts: the coronal pulp or pulp chamber, located in the crown, and the radicular pulp that 
extends from the cervical region or anatomical neck of the tooth, to the apex of the root 
(Nanci 2008; Chiego 2014). The pulp tissue can be further subdivided histologically into 
four distinct zones consisting of the odontoblastic layer at the periphery, a cell-free zone of 
Weil, a cell-rich zone and lastly, the pulp core containing the principal cells of the pulp 
(Nanci 2008). The cell-free and cell-rich zones are prominent within the coronal pulp. 
13 
The dental pulp is a heterogeneous tissue that contains odontoblasts, fibroblasts, 
undifferentiated ectomesenchymal cells, nerves, vessels and immunocompetent cells (Fig. 
2) (Nanci 2008). 
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Figure 2: Representative diagram (A) and photomicrograph (B) illustrating tooth morphology and the 
histological zones of the dental pulp. 
https:llwww.google.co.za/search?g=tooth+morphology+images (A) Nanci 2008 (B) 
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The dental pulp has five primary functions including nutritive, protective, inductive, 
formative and lastly reparative, through the production of tertiary or reactionary dentine 
(Nanci 2008; Chiego 2014). Indeed , in the adult tooth, progenitor cells are still present in 
the odontoblastic layer, and in the event of mechanical or inflammatory stimuli they are 
able to differentiate into odontoblast-like cells that secrete tertiary or reparative dentine . 
Previous studies have demonstrated that these dental pulp derived stem cells (OPSCs) are 
also able to generate diverse cell types, including neural and glial stem cells (Gronthos et 
01. 2000 ; Huang et 01. 2009) . 
Several reviews have confirmed the expression of specific mesenchymal stem cells 
markers such as STRO-I , CO 146, C090 and CD 105, CD90 (Miura et 01. 2003), and bone 
markers including bone sialoprotein, alkaline phosphatase and osteocalcin (Gronthos et 01. , 
2002). Moreover, the expression of specific markers of neural precursors ' and glial cells, 
nestin and glial fibrillary acid protein (GF AP) respectively, has also been noted in dental 
pulp stem cells (Gronthos et af. 2002). 'For all these reasons, the dental pulp is an 
interesting source of mesenchymal stem cells because of the large amount of cells 
identified and easily isolated in a non-invasive manner. 
1.3.6.2. Stem cells from the pulp of human exfoliated deciduous teeth (SHEDs) 
Evidence of dental stem cells is shown not only within the pulp tissue of permanent teeth, 
but also in the pulp tissue of deciduous teeth and other dental tissues such as the 
periodontal ligament, the dental apical papilla and the dental follicle , as confirmed by 
several studies (Miura et 01. 2003 ; Huang et af. 2009). In humans, the transition from the 
deciduous or primary dentition to the permanent or secondary dentition is a unique and 
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dynamic process in which the development and eruption of permanent teeth coincide with 
the resorption of roots or exfoliation of the deciduous teeth. 
The stem cells isolated from the pulp of exfoliated deciduous teeth (SHEDs) (F ig. 3) 
di splay an extensive aptitude to proliferation and differentiation into multipl e ce ll lineages 
similar to umbilica l cord stem cells. They have also been termed "immature DPSCs·' 
(lOPSCs) (Kerki s et al. 2006) and they exhibit a high proliferative capacity analogous to 
that of neural stem cells as suggested by the numerous and adherent aggregates of sphere-
like clusters seen in culture di shes (Miura et al. 2003). It has also been shown that after in 
vivo transplantation, in a mouse brain, they are able to induce bone, dentin and express 
similar neural markers to that of neural stem cells (Codega et af. 2014). 
Moreover, SHEDs can be isolated and successfully cultured and expanded in vitro. They 
thereby may represent a unique pool of stem cells to use for potential clinical applications 
(Kadar et al. 2009). Like the DPSCs, they express the early mesenchymal stem markers 
STRO-1 and CD 146 (Gronthos et af. 2000) as well as CD29 and CD30, more recently 
identified on SHEDs (Karaoz et al. 2010). 
1.3.6.3. Stem cells of the periodontal ligament (PDLSCs) 
Another category of dental stem cells is defined by the stem cells isolated from the 
periodontal ligament of permanent teeth (PDLSCs) (Seo at af. 2004; Coura et at. 2008). 
The periodontal ligament (PDL) is a specialised soft connective tissue situated between the 
cementum covering the root of the tooth and the inner plate of the alveolar bone housing 
the tooth (Fig. 4) (Nanci 2008). It invests the tooth and anchors it to the jawbone and helps 
it to withstand natural mast icatory forces. It occupies the periodontal space and is 
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composed of type I collagen fibres, several cells types and intercellular substance (Chiego 
2014). It has been observed by McCulloch (1995) and later by lsaka et al. (2001) that the 
periodontal ligament comprises a heterogeneous population of periodontal progenitor cells 
that primarily maintain the homeostasis, repair and regeneration of the periodontal tissue. 
They are also capable of developing into adipocyte, periodontal fibroblast , tendinoblasts as 
well as cementoblast and osteoblast precursors (Seo et al. 2004). They have been 
successfully isolated , cultured and characterised in mice and humans, and it has been 
established that they express bone-related markers such as alkaline phosphatase and bone 
sialo protein. 
Furthermore, periodontal ligament stem cells expanded in a specific inductive medium, 
express neural markers such as nestin and neural crest cell markers (Coura et al. 2008). In 
addition, it has been shown that their cell surface displays the mesenchymal stem cell 
markers STRO-J and CD 146 that are also identified in bone marrow mesenchymal stem 
cells and dental pulp stem cells (Seo et al. 2004). Again, these experiments show that the 
periodontal niche of dental stem cells represents a potentially valuable source of clinical 
material for tissue repair and regeneration (Seo et al. 2004). 
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Figure 3: Representative photograph of the pulp tissue extracted from one of the exfoliated 
deciduous teeth in the study sample. 
Figure 4: Representative photograph of the periodontal ligament ofa tooth in the study sample 
(A) and diagrammatic representation of the periodontal ligament (B). 
Nanci 2008 
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1.3.6.4. Stem cells of the apical papilla (SCAP) 
Stem cells of the apical papilla are another type of dental stem cells that have been isolated 
from the apical end of the dental papilla of the developing tooth apex (Fig. 5) (Sonoyama 
et a12006; Sonoyama et aI2008). The formation of the root during the late bell stage of 
tooth development is determined by the epithelial root sheath of Hertw ig, a double layer of 
epithelial cells originating from the enamel organ at the point where enamel secretion ends 
(Fig. 5) (Nanci 2008). The epithelial root sheath lengthens and serves as a template for the 
future root. It forms the epithelial diaphragm, an area at the proliferating and bent 
termination of the root sheath (Nanci 2008; Chiego 2014). The epithelial diaphragm 
surrounds the highly dividing cells of the apical opening of the dental pulp (Nanci 2008; 
Chiego 2014). These cells, which aggregate at the apical end of the developing root to 
form the apical papilla, contain ectomesenchymal cells that are histologically distinct from 
the dental pulp and represent a unique source of mesenchymal stem cells (Fig. 5) (Fig. 6) 
(Huang et af. 2009). They have been successfully expanded in vitro and have successfully 
undergone odontogenic, adipogenic and neurogenic differentiation demonstrated by the 
expression of bone and neural markers in the appropriate induction medium (Sonoyama et 
af. 2008). The mesenchymal stem cells marker STRO-l has also been identified on the 
cell surface (Lei et af. 2011). 
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Figure 5: Representative photographs (A and C) and photomicrograph (B) ofthe apical papilla 
of the developing permanent tooth. 
Huang et at. 2009 
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Figure 6: Representative photomicrograph of root formation steps in a permanent tooth 
showing the apical diaphragm. 
Nanci 2008 
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1.3.6.5. Stem cells of the human dental follicle (DFSCs) 
The dental follicle or dental sac is the loose and vascular ectomesenchymal tissue that 
encapsulates the dental papilla and the enamel organ of the developing tooth from the cap 
stage of tooth development (Nanci 2008). It is composed of a heterogeneous layer of 
ectomesenchymal cells (Fig. 7) that have two important functions in odontogenesis: 
namel y, the development of the periodonti um (Morsczeck et af. 2005) and the co-
ordination of tooth eruption (Nanci 2008). The periodontium is composed of the 
periodontal ligament, the alveolar bone, the cementum covering the root of the tooth and 
the lamina propria of the gingiva facing the tooth (Nanci 2008) . 
The dental follicle progenitor cells have been isolated from the dental follicles of impacted 
third molars and, in expanded cultures, they initiate the formation of adherent colonies that 
are also competent to differentiate into adipogenic, osteogenic and neural cell lineages 
(Arthur et af. 2008; Huang et af. 2009; Kadar et af. 2009; Lei et af. 2011). Like the other 
dental stem cells, the in vitro characterisation of dental follicles stem cells has reported the 
expression of the mesenchymal stem cells marker STRO-l , bone markers including 
osteocalcin, bone sialoprotein and the neural progenitor cell marker nestin and Notch-I. 
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Figure 7: Representative light microscopic pictures ofthe dental follicle of the developing permanent 
tooth. 
Nanci 2008 
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The five types of dental stem cells thus form a valuable source of adult stem cells that are 
easily accessible in a non-traumatic manner in the human. Indeed, the deciduous teeth are 
naturally lost when they are replaced by the secondary dentition in the genetically 
regulated event of dental exfoliation (Nanci 2008). This provides a source for the stem 
cells isolated from the pulp of human exfoliated deciduous teeth (SHEDs). Besides, 
healthy permanent teeth, such as maxillary and mandibular premolars, are often extracted 
for orthodontic treatment purposes. These teeth are the source of dental pulp stem cells 
(DPSCs) as well as stem cells from the apical papilla (SCAP), as at the time of tooth 
extraction, the root(s) maturation has not yet fully occurred. Furthermore, impacted 
maxillary and mandibular third molars that could be associated with pathological 
conditions are often surgically removed without detrimental health effects. These samples 
provide dental pulp stem cells as well as dental follicle stem cells (DFSCs). Finally, the 
periodontal ligament attaching the cementum of the root of the tooth to the alveolar bone is 
cut off in the extraction of all teeth and therefore supplies the periodontal stem cells 
(PDLSCs). 
It is then evident that human dental stem cells can easily be manipulated to obtain various 
multipotent cell colonies that can, not only regenerate or repair lost dental tissues, but also 
other cell lineages damaged in disease, especially neurogenic cells. Indeed, the dental stem 
cells all demonstrate the ability to neural differentiation in a specific induction medium and 
can therefore be used in regenerative medicine (Arthur et af. 2008; Ulmer et af. 2010). 
Currently, the increase of nervous system disorders, especially neurodegenerative diseases 
in the elderly population, has expanded. They lead to the degeneration of neural cells in 
the central nervous system, followed by malfunction. To repair the damaged function, 
pharmacology therapy is used but is also limited in many instances. The use of neural 
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stem cells would be the ideal treatment of these conditions. However, the location of the 
neural stem cells in the subventricular zone in the lateral ventricle and subgranular zone of 
the dentate gyrus of the hippocampus of the adult, render the harvesting of the cells 
impossible. The use of the dental stem cells would be an advantageous, reliable and non-
invasive alternative for tissue engineering. 
As previously stated, several studies performed on dental stem cells in the Asian and 
European populations have demonstrated their successful isolation, proliferation and, 
characterisation as well as their neuroregenerative properties when they are transplanted 
into the injured central nervous system of adult rats or mice (Sakai et al. 2012). This 
earlier research advocates the use of human dental stem cells as an exclusive pool of 
clinical material for tissue regeneration such as neuroregeneration therapies. To date, no 
investigation of the neurogenic differentiation of human dental stem cells in South Africa 
has been undertaken. Focusing on such a study in the South African population could 
therefore upgrade the information in the tooth-derived stem cells in order to significantly 
contribute to the treatment of neurological disorders. 
1.4. Objectives of the study 
1.4.1. Main objective 
The aim of the study was to evaluate the neurogenic potential of two categories of dental 
stem cells: namely, the dental pulp stem cells (DPSes) and the stem cells from the pulp of 
exfoliated deciduous teeth (SHEDs) in a South African population. 
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1.4.2. Specific objectives 
In order to achieve this aim, the following objectives were defined: 
I. The isolation and culture of DPSCs and SHEDs from permanent and deciduous teeth 
respectively. 
2. The characterisation of DPSCs and SHEDs using flow cytometry analysis. 
3. The induction of neurogenic differentiation ofDPSCs and SHEDs. 
4. The assessment ofthe proliferation of the differentiated DPSCs and SHEDs using Ki-
67. 
5. The assessment of the maturation of the differentiated DPSCs and SHEDs in vitro by 
using Doublecortin (DCX: neural markers for immature neurons) and Nestin (neural 
marker for mature neurons). 
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CHAPTER 2 
MA TERIAL AND METHODOLOGY 
2.1. Ethics 
The Human Research Ethics Committee (Medical) of the University of the Witwatersrand 
approved the protocol design and procedures for this study (Clearance Certificate Number 
M 120506) (Appendix A). Permission was also obtained from the Chief Executive Officer 
of the School of Oral Health Sciences of the University of the Witwatersrand for the teeth 
collection and their use for the research project. 
2.2. Study sample 
Thirty impacted and semi-impacted maxillary and mandibular molars were extracted from 
healthy adults aged between 18 and 28 years. In addition, thirty deciduous teeth were 
removed from healthy patients aged between 7 and 10 years, who had required dental 
extraction under general anaesthesia. The teeth were obtained following informed consent 
from patients and parents visiting the Wits Oral Health Clinic, Charlotte Maxeke 
Johannesburg Academic Hospital. 
A week prior to the extraction, patients were instructed to pre-treat their teeth with an 
antimicrobial prophylaxis mouth rinse of 0.2% chlorhexidine gluconate, twice a day after 
brushing, in order to reduce the microbial flora of the oral cavity (Miura e/ al. 2003; 
Morsczeck e/ al. 2009; Gronthos e/ al. 2011; Tirino e/ al. 2011). Chlorhexidine is a form 
ofbis-biguanide used as a gluconate salt. It is a positively-charged molecule that adheres 
to the negatively-charged sites on the bacteria and fungi cell wall. It impairs the integrity 
of the plasma membrane which results in leakage of cell contents and cell death 
26 
(McDonnell et al. 1999). It is therefore a broad-spectrum antimicrobial active against a 
wide range of Gram-positive and Gram-negative bacteria, fungi, facultative anaerobes and 
aerobes (Okino et al. 2004). Furthermore, it has a quicker kill time rate than other 
antimicrobials (McDonnell et al. 1999). 
2.3. Isolation and culture of DPSCs and SHEDs 
2.3.1. Tooth extraction 
On the day of the surgical procedure, aseptic techniques were followed throughout. The 
teeth were disinfected with a 0.2% chlorhexidine gel for two minutes, before the 
extraction. Following local anaesthesia of the area, the teeth were extracted using a sterile 
tooth forceps. The extracted teeth were washed with a solution of 0.2% chlorhexidine 
gluconate for two minutes, the designated time needed to kill the Candida albieans in the 
specimens (Patel et al. 2008). The teeth were then washed with distilled water to 
neutralise the action of the chlorhexidine and stop the antimicrobial effect on healthy 
tissue. The dental specimens were then deposited in a sterile solution of Hanks Balanced 
Salt Solution (HBSS) (Lonza, Verviers, Belgium) to be transported to the laboratory. 
2.3.2. Pulp tissue extraction 
Firstly, a periodontal scaler was used to remove all debris ofthe periodontal ligament 
(POL) on the roots. The teeth were then wiped with 70% alcohol and then 
circumferentially split into two halves, at the level of the cementoenamel junction, with a 
sterile tungsten fissure bur mounted on a sterile dental hand piece (Fig. 8). This was 
performed under irrigation to avoid heating of the dental tissues. The pulp tissue was then 
carefully isolated with a sterile excavator and an endodontic file and minced in a sterile 
petri dish with a sterile scalpel surgical blade. It is worth noting that to protect the pulp 
tissue from drying out it was kept wet at all times with a solution of 0.1 M phosphate 
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buffered saline (PBS) (Appendix C) (Fig. 9). The squashed tissue was then immersed into 
a digestive solution of 3mg/mL of collagenase type I (Millipore, Temecula CA, USA) and 
4mglmL of dispase (Sigma-Aldrich, St Louis Missouri, USA) (Appendix C) at 37°C, in a 
water bath and under gentle shaking for 1 hour and 30 minutes to facilitate pulp tissue 
dissolution. 
Figure 8: Representative photographs of teeth from the study sample: extracted deciduous tooth (A), 
permanent tooth (B), extracted deciduous tooth spilt using the bur(C) and permanent tooth cut at the 
cementoenamel junction (D). 
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Figure 9: Representative photographs of the dental pulp tissue extraction with an endodontic file (A), 
the entire extracted dental pulp tissue (B), the minced dental pulp tissue, in a petri dish (C) and 
collected on the sterile scalpel surgical blade (D). 
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2.3.3. Pulp tissue culture 
After the enzymatic digestion, the cell suspension was centrifuged in PBS at 400 x g for 10 
minutes, filtered with 70 !-.lITI Falcon cell strainers and resuspended in a cionogenic medium 
composed of alpha-Modified Eagle's Medium (Lonza, Verviers, Belgium), supplemented 
with the following: 20% Foetal Bovine Serum (FBS) (Lonza, South Africa) 100 J,ll 
ascorbic acid 2-phosphate (Sigma-Aldrich, St Louis Missouri, USA), 2 mM L-glutamine 
(Lonza, Verviers, Belgium), 100 U/ml penicillin, and 100 J,lg/ml streptomycin (Lonza, 
Walkerville, USA), 250 J,lg/ml fungizone (Flow Laboratories, UK) and 5 x 10-5 M p-
mercaptoethanol (Calbiochem, Darmstadt, Germany) (Appendix C). The cells were then 
cultured in 25 ml Nunc® flasks at 37°C in a 5% C02 humidified incubator (Heraeus Hera 
Cell 150). At this stage, the cells were presumed to be at passage 0 (PO). 
After 3 days of culture, the non-adherent cells and the remnants of pulp tissue were washed 
with PBS and a fresh cionogenic growth medium was added. At days 7, 14 and 22 of 
culture, the primary expanded cells were enzymatically treated and passaged using 
Accutase (Sigma-Aldrich, St Louis Missouri, USA) in phosphate buffered saline. The use 
of accutase was preferred to trypsin-EDT A in order to avoid the occurrence of auto 
fluorescence of the cells during the flow cytometric analysis. The cultured medium was 
poured out of the flask, replaced by PBS to wash the cells twice. The cells were then 
incubated for 3 minutes in 2 ml of accutase_ 
Afterwards, the cells were rinsed twice with PBS and then centrifuged at 1200 rpm for 5 
minutes. The cell pellet was resuspended in a wash buffer (PBS with 1 % FBS) to quench 
the enzyme and filtered through a 70J,lm cell strainer and one group of the cell colonies 
were stained with trypan blue (BDH Chemical, England) to assess cell viability. This test 
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is based on the principle that viable cells possess intact membranes that are not permeable 
to trypan blue dye. Dead cells on the other hand, do have perforated cell membranes that 
incorporate trypan blue. 50 fll of cell suspension was incubated with 1 ml trypan blue 
solution for 1 minute at room temperature. Thereafter, viable and dead cells were counted 
using a haemocytometer chamber (Bright-Line® American Optical Company) under a 
light microscope at xl 0 magnification. A cell count grid was used and the number of 
unstained cells in the five indicated blocks was obtained and averaged. The number of 
cells per millimetre was first ascertained and then the total percentage of viable cells was 
obtained using the following formula (Appendix B): 
Number of cells/ml = average value x dilution factorx 1 04 
Total percentage of viable cells = number of viable cells (/m1)i number of dead cells (/ml) 
x 100 
The second group of expanded cells was stained for the flow cytometry analysis and the 
last group was transferred into a 75ml culture flask and replaced into the incubator to allow 
the cells to further expand and proliferate. This enzymatic detaching procedure was 
performed at days 7, 14 and 21 and the cells were considered to be at passage 1 (P 1), 
passage 2 (P2) and passage 3 (P3) respectively. 
2.4. Flow cytometry analysis 
2.4.1. Flow cytometry requirements on mesenchymal stem cells 
In 2006, the International Society for Cellular Therapy (lSCT) proposed the term 
"multi potent mesenchymal stromal cells" and postulated a set of standards to define human 
mesenchymal stem cells for both laboratory-based scientific investigations and for pre-
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clinical studies (Dominici et al. 2006). It was decreed that in order to unequivocally 
establish the phenotype of mesenchymal stem cells, three minimum criteria ought to be 
met: the adherence to plastic culture dishes, the multipotent differentiation potential and 
the expression of specific surface antigens or clusters of differentiation (CD) (Dominici et 
at. 2006). These markers which define the mesenchymal stem cells surface and their 
internal molecules are CD73, CD90 and CD I OS, as measured by flow cytometry (Dominici 
et at. 2006). Furthermore, the cells must lack the expression of specific haematopoietic 
stem cell markers such as CDI4, CD34 and CD45 (Dominici et al. 2006). Additionally, it 
has been demonstrated that dental stem cells also display a specific markers profile similar 
to those of mesenchymal stem cells (Gronthos et al. 2002; Foudah et al. 2013). 
2.4.2. Antibodies selection and gating strategy 
In an attempt to verify the mesenchymal stem cell identify and to ascertain the purity of the 
isolated cells, a negative and a positive selection was adopted for this multicolour flow 
cytometry experiment. A specific gating strategy was developed to evaluate the phenotype 
of culture-expanded cells obtained from the dental pulp of both deciduous and permanent 
teeth. To this end, the analysis panel had to include, in the negative selection, CD45 and 
CD 14 in order to positively exclude cells of haematopoietic and monocytic lineage 
respectively. This allowed the positive discrimination of the haematopoietic stem cells, as 
the remaining unstained cells represented the population to gate in order to identify the 
cells of interest. This gating strategy also ought to include, in the positive selection, the 
known mesenchymal stem cell markers: CD90 was thus selected to stain for non-
haematopoietic lineage, followed by CD29 and CD44 to select for dental stem cell lineage. 
Finally, CD 105 was chosen for the CD44+ and CD29+ cells to ascertain further 
mesenchymal stem cell lineage. 
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For this 6-colour flow cytometry analysis, the BDTM Biosciences LSRFortessa flow 
cytometer was used. Flow cytometers operate by focussing a laser beam onto a sample of 
cells that are hydrodynamically focused into a unicellular flow. The cells are individually 
detected and illuminated as they pass through the laser beam and the signal from each 
interrogated cell is directed to the selected optical detectors. Photomultiplier tubes then 
detect the amount of forward and side scatter from each cell. The size of the cell will 
determine the quantity of light that is scattered in the forward direction and the internal 
complexity and granularity of the cell will determine the side scatter. Any fluorescent 
molecules such as the conjugated fluorochrome antibody that is present in the cell or on the 
cell membrane will fluoresce, as the cell is illuminated by the laser beam. The intensity of 
emitted light depends on the peak absorbance wavelength determined by the nature on the 
fluorochrome antibody. 
It is important to state that throughout this flow cytometry analysis, monoclonal antibodies 
were preferred as, since they originate from a single clone, they are more specific and 
exhibit low cross-reactivity. Furthermore, for each antibody, titration was performed to 
determine the optimal antibody concentration as well as the position of the negatively 
stained population on the axis (Appendix E). Finally, the specific compensation for the 
procedure was conducted to set the lowest voltage that will give the primary fluorescence 
signals in each channel (Appendix F). This was always performed prior to the data 
collection with the flow cytometer in order to avoid any fluorescence spill-over across 
channels. 
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2.4.3. Sample preparation for flow cytometry 
At each designated enzymatic passage (PI, P2 and P3) the flow cytometry analysis was 
performed with the semi-confluent and confluent stages observed at P2 and P3. The 
number of cells that were routinely recovered was approximately I x 105 per tooth. The 
cells treated with accutase were rinsed twice in 0.1 M phosphate-buffered sal ine (PBS), and 
then resuspended in a wash of blocking buffer consisting of PBS containing 1 % foetal 
bovine serum (FBS) (Lonza, South Africa). Samples were then assayed at a density of I x 
105 cells/ml, in a 4 ml round bottom propylene tube. They were incubated at room 
temperature and in the dark, for approximately 20 minutes and stained with the 
fluorescence-conjugated monoclonal antibodies at the concentrations established during 
the titration process. The determined dilutions in 90 III of wash buffer were the following: 
2.5 III ofCD45 in (CD45 V450 mouse anti-human BD Horizon TM, Sigma-Aldrich, St 
Louis Missouri, USA), 1.25 III ofCDI4 (CD14 APC-H7 mouse anti-human BD 
Pharmingen™, San Diego CA, USA), 2.5 III ofCD29 (CD29 PE anti-human BioLegend, 
San Diego CA, USA), 1.25 III ofCD44 (CD44 FITC anti-human BioLegend, San Diego 
CA, USA), 1.25 III ofCD90 (CD90 PE-CyTM mouse anti-human BD Pharmingen™, San 
Diego CA, USA) and 2.5 III ofCD105 (CDI05 APC anti-human BioLegend, San Diego 
CA, USA). 
After the incubation period, the cell suspensions were then washed with I ml of wash 
buffer solution added to the tube and then centrifuged twice at 400xg for 5 minutes. The 
supernatants were aspirated and the cell pellets were fixed in 200 III of 1% 
paraformaldehyde for 10 minutes at room temperature. I ml of PBS was then added to the 
cell suspensions that were then rinsed by centrifugation at 400xg for 5 minutes. Following 
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this, the decantation process was again performed by removing the supernatant and 
resuspending the resulting cell pellets in I ml of PBS for the flow cytometry analysis. 
The control cells included the unstained cells that were transferred in a 4 ml round-bottom 
propylene tube, washed in 1.ml of PBS and centrifuged at 200 x g for 10 minutes, then 
fixed in 200 ~I 1 % paraformaldehyde for 10 minutes at room temperature. Following the 
fixation, the cell suspensions were rinsed in 1 ml of PBS and centrifuged again at 200 x g 
for 10 minutes. The supernatant was removed and 1 ml of PBS was added to the 
suspension for the subsequent analysis by the flow cytometer. 
As previously mentioned, approximately one hundred thousand cells were acquired and 
recorded by the flow cytometer for each analysis. The negative selection was first 
performed and fluorochrome conjugated monoclonal antibodies against haematopoietic 
cell markers CD45 and CDI4 were used. This was then followed by the positive selection 
of mesenchymal stem cells using the established markers: fluorochrome conjugated 
monoclonal antibodies against CD29, CD44, and CD105. The data was obtained with BD 
FACDiva software and was then analysed using FlowJo software (v9.4.11 TreeStar Inc) 
following the specific developed gating strategy. 
2.5. Neural induction 
2.5.1. Neural markers in dental stem cells 
It has been demonstrated that human dental pulp stem cells are able to express neural 
markers such as nestin, doublecortin (DCX) and neuN due to the migration of neural crest 
cells into the developing tooth germ (Arthur et al. 2008, Gervois et al. 2015). It has also 
been shown that human DPSCs secrete neurotrophic growth factors such as brain-derived 
neurotrophic factor (BDNF) (Martens et al. 2012), as well as angiogenic factors such as 
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vascular endothelial growth factor (VEGF) and other proangiogenic growth factors such as 
platelet-derived growth factors (PDGF) (Bronckaers et af. 2013) suggesting that hDPSCs 
can adequately sustain neuronal cells and this was demonstrated both in vitro but also in 
various in vivo following transplantation ofhDPSCs in experimental animals (Sakai et af. 
2012). In this experiment, only the secretion of doublecortin and nestin was investigated. 
2.5.2. Neural differentiation 
After the flow cytometry analysis, the now phenotyped DPSCs and SHEDs were seeded in 
6-well plates at a concentration of2 x 10 3 cells per ml of the neuroinductive medium: 
Neurobasal™ A Media (Gibco®, UK) supplemented with B27® Supplement XenoFree 
(Gibco®, UK), 50 U/ml penicillin, 50 Ilg/ml streptomycin (Lonza, Walkerville, USA) 20 
ng/ml epidermal growth factor (EGF) (Sigma-Aldrich, St Louis Missouri, USA), 40 ng/ml 
basic fibroblast growth factor (FGF) (Sigma-Aldrich, St Louis Missouri, USA) (Appendix 
C). The cells were incubated at 37°C in a 5% C02 atmosphere in an air humidified 
incubator for 7 days. The cells were carefully washed and the medium changed every 3 
days: the free-floating cells were collected, rinsed with 0.1 M phosphate buffered saline 
(PBS) and resuspended in a new neurogenic medium. The cell colonies, referred to as 
neurospheres, were kept floating in the culture medium and their size closely monitored, so 
as not to interfere with the cell viability and the differentiation capacity (Gervois et af. 
2014). 
On day 7, the cells were again collected, washed and resuspended in a new medium 
consisting of Dulbecco's Modified Eagle's medium (DMEM) (Lonza, Verviers, Belgium), 
supplemented with Insulin-Transferrin-Selenium-X (Gibco®, UK), 50 U/ml penicillin, 50 
Ilg/ml streptomycin (Lonza, Walkerville, USA) and 40 ng/ml basic fibroblast growth factor 
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(FGF) (Sigma-Aldrich, St Louis Missouri, USA) (Appendix C), and the cells were cultured 
for an additional 7 days. The experimental cells to be used for immunocytochemistry were 
seeded in 6-well plates at a concentration of2 x 103 cells per ml of the neural progenitor 
basal medium. The control cells were seeded at the same concentration in the clonogenic 
culture medium. 
On day 14, all-trans retinoic acid (ATRA) (Sigma-Aldrich, St Louis Missouri, USA) was 
added to the medium. Cells were kept under neurogenic maturation-promoting conditions 
until confluency was reached at approximately day 21. Again, the experimental cells to be 
used for immunocytochemistry were seeded in coated 6-well plates at a concentration of2 
x 103 cells per ml of the neuroinductive medium. The control cells were seeded at the 
same concentration in the clonogenic culture medium. After 7, 14 and 21 days of neural 
induction, corresponding to enzymatic passages 4 (P4), 5 (P5) and 6 (P6) respectively, the 
cells were processed for the immunocytochemistry analysis. 
2.6. Immunocytochemistry analysis 
2.6.1. Ki-67 
Ki-67 is a non-histone nuclear antigen (395 kOa) with its gene located on chromosome 10. 
lt is exclusively synthesized in the proliferative phases ofthe cell cycle (late Gl, S, G2 and 
M phases) (Fisher et al. 2002; Potemski et al. 2006; Faratzis et al. 2009). Ki-67 is not 
exhibited during the resting phase of the cell, which renders it a reliable nuclear marker for 
the determination of the proliferative activity of a cell. Indeed, when it is conjugated with 
the specific mononuclear antibody to Ki-67, it is recognized and only the cells undergoing 
active division are stained (Fisher et al. 2002). 
37 
Before the culture of the neural induced dental stem cells, a 6-well culture plate was 
prepared by placing a sterilized glass cover slip (22mm X 22mm) in each of its wells. The 
cover slips were washed with sterile PBS (Appendix D) then the cells were seeded on to 
them at a concentration of 1 x 106 cells per m!. Afterwards, the cells were incubated at 37° 
C in a 5% C02 atmosphere in an air humidified incubator until con fluency was reached. 
At days 7,14 and 21, the immunocytochemistry experiments were performed. The 
designated reagents were added to the cells in each of the wells, following which the 
fixative procedure with 4% paraformaldehyde was performed for 30 minutes at room 
temperature and under the laminar flow hood. After the fixing, the 4% paraformaldehyde 
was removed and each well was rinsed once with Tris-Buffered Saline (TBS) (Appendix 
D). The buffer was then thoroughly removed and replaced in each well, with 1 mlofthe 
blocking buffer (TBS 5.5% goat serum) for 1 hour. The cells were then rinsed off with 1 
ml ofTBS and finally incubated with a mouse monoclonal anti Ki-67 (Sigma, South 
Africa) overnight and at 4°C. 
In the negative controls specimens, TBS alone was added while the antibody was omitted. 
The following day, each well was thoroughly washed with 1 ml TBS/Triton twice for 5 
minutes then once with TBS and finally incubated with a polyclonal goat anti-mouse 
biotinylated secondary antibody (Dako, South Africa) diluted in TBS 3% bovine serum 
albumin for 1 hour at room temperature. 
Subsequent to this, the cells were incubated for 30 minutes in 0.6% hydrogen peroxide in 
TBS at room temperature. After the elapsed time, the solution was aspirated, and the cells 
were once again rinsed three times with 1 ml TBS/Triton for 5 minutes before the 
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incubation with 800111 Vectastain ABC Kit (Dako, South Africa) for 1 hour at room 
temperature. The solution was completely aspirated, and the cells washed twice for 5 
minutes with I ml TBS. Then, 1 ml of diaminobenzidine tetrahydrochloride (DAB) reagent 
(Sigma. South Africa) (Appendix D) was added into each well. This reaction was carefully 
monitored using a microscope in order to reduce any background effect. The reaction was 
then terminated by adding I ml of sterile distilled water into each well. This solution was 
aspirated and the cells washed once again with 1 ml of sterile distilled water. The cover 
slips were dipped twice each in a graded series of alcohol and then in two changes of 
xylene before being mounted with Entellan (Merck, South Africa) on to glass slides (lmm 
X 76mm X 26mm). After reaction with Diamino benzidine reagent (DAB), the Ki-67 
immunolabelled cells were counted in all sections on the Axiovision light microscope 
using X63 lens. The Ki-67 positive proliferative cells were counted at days 7, 14 and 22 
after neural induction. 
2.6.2. Doublecortin 
Doublecortin (DeX) is a microtubule binding phosphoprotein (40kDa) which is expressed 
in actively proliferating and migrating immature neurons in embryonic and adult 
neurogenesis structures (Brown et al. 2003; Bohlen et al. 2007). It is associated with the 
migration of neuronal precursor' cells. DCX is encoded by a gene located on the X 
chromosome and was originally described in lissencephaly, one of the most severe 
malformations of the human cerebral cortex (des Portes et al. 1998; Gleeson et at. 1998). 
The DCX immunolabelling procedures were performed on free-floating sections of neural 
induced DPeSs and SHEDs. 
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Sections were firstly washed 3 times for 10 minutes in PBS, rinsed once with TBST for 5 
minutes under gentle shaking and at room temperature. They were then transferred into an 
endogenous peroxidase inhibitor solution (49.2% 0.1 M phosphate buffer, 49.2% methanol, 
1.6% of 30% H202) for 30 minutes. After 3 rinses in 0.1 M phosphate buffer for 10 
minutes, the sections were treated with a blocking solution (3% normal rabbit serum, 2% 
bovine serum albumin, 0.25% Triton X-I 00 in 0.1 M phosphate buffer) for 2 hours under 
gentle shaking at room temperature to avoid non-specific binding. The tissues were then 
transferred into the primary antibody solution (1 :300, goat anti-DCX) (Biotechnology, 
Santa Cruz, USA) in the blocking buffer solution ofTBST and incubated for 48 hours at 
4"C under gentle shaking. 
Following the incubation period, the tissues were removed from the refrigerator, placed on 
a shaker to equilibrate at room temperature and then washed 3 times in O.IM phosphate 
buffer for 10 minutes and under gentle shaking before the incubation in the secondary 
antibody solution consisting of: 1: I 000 dilution ofbiotinylated anti-goat IgG (BA-5000, 
Vector Laboratories, Burlingame, CA, USA) in 3% normal rabbit serum and 2% bovine 
serum albumin in 0.1 M phosphate buffer for 2 hours at room temperature and under gentle 
shaking. Sections were then subjected to a 10 minutes rinse in 0.1 M phosphate buffer 3 
times and under gentle shaking. After the rinse, the sections were incubated in an A vidin-
Biotin solution consisting of 1: 125 A reactive and 1: 125 B reactive (Vector Laboratories, 
Burlingame, CA, USA) in 0.1 M phosphate buffer for 1 hour. The sections were once 
again washed into 0.1 M phosphate buffer 3 times and for 10 minutes before being 
transferred for 5 minutes into a solution of 0.05% diaminobenzidine (DAB) in 0.1 M 
phosphate. Each I ml vial of the solution was supplemented with 3.3 f.ll of30 % H202, 
then mixed and allowed to develop under a low power stereo microscope until the 
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appearance of definite nuclear staining. The reaction was subsequently arrested by 3 final 
10 minutes rinses of the sections in O.IM phosphate buffer. The tissues were then mounted 
on 0.5% gelatinized slides, air-dried overnight, dehydrated in an ascending graded series of 
alcohols, cleared in xylene and then coverslipped with Depex. In the control sections, the 
same protocol was repeated but the primary antibody was omitted. After the reaction, the 
DeX immunolabelled cells were qualitatively analysed under the light microscope and 
quantitatively analysed using the click counter at days 7, 14 and 21 after neural induction. 
2.6.3. Nestin 
Nestin is a high molecular weight (240kDa) protein with its gene located on chromosome 1 
(Guerette et al. 2007). Nestin belongs to the class VI of intermediate filaments of the 
cytoskeleton (Michalczyk et al. 2005; Guerette et al. 2007) and is exhibited in nervous, 
muscular, cardiac tissues and the neural crest cells and testis (About et al. 2000). In the 
central nervous system, nestin is mainly expressed at the early stages of development and 
is then replaced by neurofilaments and it is a neural-specific protein expressed in the neural 
stem cells (Bohlen et al. 2007). 
The nestin immunolabelling procedures were performed on free-floating sections of neural 
induced DPeSs and SHEDs. Sections were firstly washed 3 times for 10 minutes in PBS, 
rinsed once with TBST for 5 minutes under gentle shaking and at room temperature. They 
were then transferred into an endogenous peroxidase inhibitor solution (49.2% O.1M 
phosphate buffer, 49.2% methanol, l.6% of30% H202) for 30 minutes. After 3 rinses in 
0.1 M phosphate buffer for 10 minutes, the sections were treated with a blocking solution 
(3% normal rabbit serum, 2% bovine serum albumin, 0.25% Triton X-lOO in O.IM 
phosphate buffer) for 2 hours under gentle shaking at room temperature to avoid non-
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specific binding. The tissues were then transferred into the primary antibody solution: 
1:5000 nestin (Novocastra laboratory (NCL), Wetzlar, Germany) in the blocking buffer 
solution ofTBST and incubated for 48 hours at 4°C under gentle shaking. Following the 
incubation period, the tissues were removed from the refrigerator, placed on a shaker to 
equilibrate at room temperature and then washed 3 times in 0.1 M phosphate buffer for 10 
minutes and under gentle shaking before the incubation in the secondary antibody solution 
consisting of: 1 :1000 dilution ofbiotinylated anti-goat anti rabbit (Vector Laboratories, 
Burlingame, CA, USA) in 3% normal goat serum and 2% bovine serum albumin in TBST 
for 1 hour at room temperature and under gentle shaking. Sections were the subjected to a 
10 minutes rinse in 0.1 M phosphate buffer 3 times and under gentle shaking. After the 
rinse, the sections were incubated in an Avidin-Biotin solution consisting of 1: 125 A 
reactive and 1:125 B reactive (Vector Laboratories, Burlingame, CA, USA) in O.IM 
phosphate buffer for 1 hour. The sections were once again washed into 0.1 M phosphate 
buffer 3 times and for 10 minutes before being transferred for 5 minutes into a solution of 
0.05% diaminobenzidine (DAB) in O.IM phosphate. Each 1 ml vial of the solution was 
supplemented with 3.3 III of 30 % H202, then mixed and allowed to develop under a low 
power stereo microscope until the appearance of definite nuclear staining. The reaction 
was subsequently arrested by 3 final 10 minutes rinses of the sections in 0.1 M phosphate 
buffer. The tissues were then mounted on 0.5% gelatinized slides, air-dried overnight, 
dehydrated in an ascending graded series of alcohols, cleared in xylene and then 
covers lipped with Depex. In the control sections, the same protocol was repeated but the 
primary antibody was omitted. After the reaction, the nest in immunolabelled cells were 
qualitatively analysed under the light microscope and quantitatively analysed in all 
sections on the Axiovision light microscope using X63 lens at day 7, 14 and 21 after neural 
induction. 
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CHAPTER 3 
RESULTS 
3.1. Cell culture 
3.1.1. Descriptive analysis of culture-expanded cells 
Cells from the pulp tissues of permanent and deciduous teeth were successfully isolated. 
The culture-expanded cells were examined under an Olympus CX 41 inverted phase 
contrast microscope at x 100, x 200 and x 400 magnifications. The results were always 
simultaneously noted in the two experimental groups. At day 1 of cell culture, the flasks 
were observed to ascertain that the cells were allowed to grow in a culture medium devoid 
of microbial contamination, and several floating, very small and round cells were seen in 
the two experimental groups (Fig. lOA). After 3 days of culture, the first signs of adherent 
clusters of cells were observed in each flask (Fig. lOB). The cells were exhibiting a less 
rounded and more elongated shape. Non-adherent floating cells and cell debris were also 
present in the culture medium and they were washed off using PBS. 
After 7 days of culture, more colony forming units of cells (CFU) were noted in both 
deciduous (Fig. 11) and permanent culture flasks (Fig. 12); they were spindle-shaped 
fibroblast-like cells displaying the typical mesenchymal stem cell shape. Their adherence 
to the tissue culture flask was evident and they were expanding, although not showing cell 
to cell contact. In addition, very few isolated cobble-stone-like cell formations were 
observed in each population. After 14 days of culture, most of the cells extracted from the 
pulp of deciduous (Fig. 13) and permanent teeth (Fig. 14) became semi-confluent and 
exhibited limited cell to cell contact. Confluency was reached after 21 days of culture in 
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the permanent teeth (Fig. 16). However, some delay of 2 to 3 days in the culture-expanded 
cells extracted from the pulp of the deciduous teeth (Fig. 15) was observed. 
Figure 10: Representative photomicrographs of the cell culture observed in both deciduous and 
permanent teeth at day I (A) and day 3 (B) (x 100). 
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DAY 7: DECIDUOUS TEETH 
Figure 11: Representative photomicrographs of the cell culture in 
deciduous teeth at day 7, x 100 (A), x200 (8) and x400 (C). 
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DAY 7: PERMANENT TEETH 
Figure 12: Representative photomicrographs ofthe cell culture in permanent teeth at 
day 7, x 100 (A), x200 (B) and x400 (C). 
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DAY 14: DECIDUOUS TEETH 
Figure 13: Representative photomicrographs of the cell culture in deciduous 
teeth at day 14, x 100 (A), x200 (B) and x400 (C). 
47 
DAY 14: PERMANENT TEETH 
Figure 14: Representative photomicrographs of the cell culture in permanent 
teeth at day 14, x 100 (A), x200 (8) and x400 (C). 
48 
DAY 21: DECIDUOUS TEETH 
Figure 15: Representative photomicrographs ofthe cell culture in deciduous 
teeth at day 21 , x 100 (A), x200 (B) and x400 (C). 
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DAY 21: PERMANENT TEETH 
Figure 16: Representative photomicrographs of the cell culture in permanent teeth at 
day 21, x 100 (A), x200 (B) and x400 (C). 
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3.1.2. Quantitative analysis of culture-expanded cells 
3.1.2.1. Percentage of viable culture-expanded cells 
The descriptive analysis included the continuous variables of the percentage of viable 
culture-expanded cells, in both deciduous and permanent teeth, and was anal ysed and 
summarised by using the mean, standard deviation , median and interqual1ile ran ge, and 
their distribution was illustrated with bar column graphs (Fig. 17). FUl1hermore, the 
relationship between the percentages of viable culture-expanded cells at days 7, 14 and 21 
was determined by a one-way repeated analysis of variance (AN OVA). 
The mean indices of the percentage of viable culture-expanded cells for both deciduous 
and permanent teeth were calculated at days 7, 14 and 21 and they are shown in Tables 1 
and 2. 
S1 
Table 1: Mean indices of the percentage of viable culture-expanded cells in deciduous 
teeth at days 7, 14 and 21. 
Day Number of teeth Mean percentage of viable cells (SD) Range 
Day 7 30 73.4 (10.1 ) 48-89% 
Day 14 30 63.3 (9.1 ) 42-81 % 
Day 21 30 54.4 (9.9) 35-75% 
Table 2: Mean indices of the percentage of viable culture-expanded cells in permanent 
teeth at days 7,14 and 21. 
Day Number of teeth Mean percentage of viable cells Range 
(SD) 
Day 7 30 75.2 (9.9) 56-89% 
Day 14 30 65.8 (10.5) 40-82% 
Day 21 30 56.3 (11.0) 36-75% 
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Figure 17: Representative histograms of the percentage of viable culture-expanded cells at day 7 for 
deciduous (A) and permanent (8) teeth, at day 14 for deciduous (C) and permanent (D) teeth and at day 
21 for deciduous (E) and permanent (F) teeth. The percentage of cells within the total of 30 specimens, 
for each population, is represented in the y-axis. 
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3.1.2.2. Comparative analysis of viable culture-expanded cells 
For each time point and in both populations, the mean percentage of viable culture-
expanded cells were statistically compared using an analysis of variance (ANOVA) and 
they were all significantly different to each other (p<O.OOO 1), as it is illustrated in Fig. 18. 
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Figure 18: Representative graph of the comparison of the percentage of viable culture-expanded cells at 
days 7, 14 and 21, in deciduous (A) and permanent (8) teeth. The error bars denote the 95% confidence 
interval for the mean. 
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3.2. Flow cytometry 
3.2.1. Descriptive flow cytometric analysis of culture-expanded populations 
Flow cytometry analysis confirmed the CD44+ CD90+ CD lOS and CD29+ CD90+ CD I OS+ 
profile of the expanded cultured cells obtained from the dental pulp of permanent and 
deciduous teeth respectively. Furthermore, the CD 14- CD45" profile was also established, 
thus confirming the absence or low percentage of haematopo ietic stem cells. Cells 
exhibited slightly altered scattered properties possibly due to the persisting heterogeneity 
of the cells in the cultured pulp tissue, despite the enzymatic digestion in collagenase and 
dispase prior to the incubation. Thus, only those cells which exhibited the traditional side 
scatter (SSC) properties, associated with cell (DPSCs or SHEDs) granularity or internal 
complexity and forward scatter (FSC) properties, associated with cell size, were analysed 
further (Fig_ 19A, Fig. 20A). 
Following the flow cytometric interrogation, analysis of the co-expression of primarily 
CD29, CD90 and CDIOS cell surface markers for the deciduous tooth and the co-
expression of CD44, CD90 and CD lOS cell surface markers for the permanent tooth was 
performed. In the both deciduous and permanent teeth, the first population obtained was 
designated CD4sbright+ CD 14bright+, and identified the cells ofhaematopoietic and 
monocytic origin (Fig. 19B, Fig. 20B). The percentage of these cells was S2.2% and 
SO.6% in both deciduous and permanent samples respectively (Fig. 21). The second flow 
cytometry event was gated on the remaining CD45" CD 14- cells and demonstrated four 
distinct populations based on the total percentage of non-haematopoietic cells acquired 
(74 .S% in both populations) (Fig. 19C, Fig. 20C). In the deciduous teeth, these 
populations were designated CD44dim CD29+ CD29bright+ (Fig. 19C), CDIOS+ CD29bright + 
(Fig. 19D), CD90+ CD29bright (Fig. 19E) and CD IOS+ CD90+ (Fig. 19F). In the permanent 
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teeth, the resulting populations were designated CD44bright + CD29bright + (Fig. 20C), 
CD44bright + CD29dim (Fig. 20C), CDloyntennediate + CD44bright + (Fig. 20D), CD90+ 
CD44bright + (Fig. 20£) and CD90bright CDlos bright (Fig. 20F). 
In the deciduous tooth sample, investigations into the CD29bright + population which 
comprised 77.2% (Fig. 19C) of the total population, revealed a negligible contaminating 
population of CD29- cells which nevertheless exhibited CD90+ expression and 
CD I os intermediate + expression (Fig. 19F). In the permanent tooth sample, investigations into 
the CD44bright + population which also dominated the total population (74.S%) (Fig. 20C) 
revealed a small contaminating population of CD44- cells which nevertheless also 
exhibited CD90+ expression and CD 1 osintennediate + expression (Fig. 20F). A relationship 
between CD44 and CD29 surface cell markers was noted as they were both exhibited, 
although in different percentages, in both types of tooth (Fig. 21). In the deciduous tooth, 
the CD44dim population (Fig. 21 A), co-expressed CD90dim and CD 1 osdim (Fig. 21 C, Fig. 
21D) and the dominating CD29bright population (Fig. 21A) expressed comparative levels of 
CD90+ and CDI osintennediate (Fig. 21 C, Fig. 21 D). In the permanent tooth, the CD29dim 
population (Fig. 21 F), primarily co-expressed CD90dim (Fig. 21 G) and the notably large 
CD44bright population (Fig. 21£) expressed comparative levels ofCD90+ CDI0sintermediate 
and CDlOS+ (Fig. 21G, Fig. 21H). The flow cytometry analysis was repeated at day 7, 14 
and 21 and each time, the results obtained analysed by the FlowJo software (v9.4.11 
TreeStar Inc) were similar to the ones previously described. 
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Figure 19: Representative Scatterplots illustrating flow cytometric analysis of the C D29 cells population. 
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Figure 21: Representative histograms of the flow cytometric analysis of the CD29 population (A, B, C and 
D) and the CD44 population (E, F, G and H). 
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3.2.2. Quantitative flow cytometric analysis of culture-expanded populations 
3.2.2.1. Percentage of CD29+ and CD44+ cells 
The mean indices of the percentage ofCD29+ and CD44+ cells was calculated by the 
Flow.lo software (v9.4.11 TreeStar Inc) and the distribution of the data at days 7, 14 and 21 
is shown in Tab les 3 and 4. 
Table 3: Mean indices of the percentage ofCD29+ cells. 
Day Number of teeth Mean percentage of CD29+ cells Range 
(SD) 
Day 7 30 55 (7.0) 39-67% 
Day 14 30 66.3 (9 .1) 42-81 % 
Day 21 30 72.2 (10.0) 48-89% 
Table 4: Mean ind ices of the percentage of CD44+ cells. 
Day Number of teeth Mean percentage of CD44+ cells Range 
(SD) 
Day 7 30 50.7 (7.9) 35-62% 
Day 14 30 56.3 (7.1) 39-68% 
Day 21 30 74.4 (2.1 ) 49-89% 
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Figure 22: Representative bar column graphs of the percentage ofCD29+ (A) and CD44+ (B) at day 21. 
PI corresponds to the percentage ofCD45+ CDI4+ haematopoietic cells that are excluded from the second 
flow cytometric event. 
P2 represents the population ofCD29+ cells (SHEDs) and CD44+ cells (DPCSs) acquired from the CD45-
CDI4- non haematopoietic cells. 
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3.3. Neural differentiation 
3.3.1. Descriptive analysis of neuronal differentiated cells 
The two populations of characterised dental stem cells, SHEDs and DPSCs transferred in 
the neural inductive medium exhibited distinct morphological changes during the 
differentiation process. Before the change of the neural basal medium to the DMEM , both 
types of dental stem cells were arranged in clusters of floating neurospheres. From day 7, 
their phenotype was similar to those of mesenchymal stem cells; however, they were more 
elongated and started exhibiting some dendritic process . After day 14 and until day 21 , 
both SHEDs and DPSCs acquired the morphological characteristics of neuronal cells: they 
were showing a rather large and round cellular body as well as various cytoplasmic 
extensions that were arranged in an intercellular network (Fig. 23). It is worthy to note that 
these images were consistent in both stem cell populations and that the differentiation 
process followed the same steps as well. 
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Figure 23: Representative photomicrographs of the neural differentiated cells in both 
deciduous and permanent teeth at days 7, x 100 (A), 14 x 100, (B) and 21 x200 (C) . 
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3.3.2. Quantitative analysis of neuronal differentiated cells 
3.3.2.1. Percentage of viable neuronal differentiated cells 
The descriptive analysis included the continuous variables of the percentage of viable 
neuronal differentiated cells, in both deciduous and permanent teeth , and was analysed and 
summarised by using the mean, standard deviation , median and interqual1ile range, and their 
distribution was illustrated with bar column graphs. Furthermore, the relationship between 
the percentages of viable differentiated neural cells at days 7, 14 and 21 was determined by 
a one-way repeated analysis of variance (ANOvA). 
The mean indices of the percentage of viable differentiated neural cells for both deciduous 
and permanent teeth were calculated at days 7, 14 and 21 and they are shown in Tables 5 
and 6. 
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Table 5: Mean indices of the percentage of viable neuronal differentiated cells in 
deciduous teeth, at days 7, 14 and 21. 
Day Number of teeth Mean percentage of viable cells (SD) Range 
Day 7 30 51.2 (8.1) 36-66% 
Day 14 30 53.3 (8.9) 39-67% 
Day 21 30 68.1 (5.3) 56-78% 
Table 6: Mean indices of the percentage of viable neuronal differentiated cells in the 
permanent teeth, at days 7, 14 and 2l. 
Day Number of teeth Mean percentage of viable cells Range 
(SD) 
Day 7 30 53.3 (8.2) 36-66% 
Day 14 30 58.8 (8.8) 41-69% 
Day 21 30 63.3 (9.1) 42-81 % 
3.3.2.2. Comparative analysis of viable differentiated neuronal cells 
For each designated time point, the mean percentage of viable neuronal differentiated cells 
were statistically compared using an analysis of variance (ANOVA) and they were all 
significantly different to each other (p<O.OO 1), as it is illustrated in Fig. 24. 
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Figure 24: Representative graph of the comparison of the percentage of viable neural differentiated cells 
at days 7, 14 and 21 , in deciduous (A) and permanent (B) teeth, 
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3.4. Immunocytochemistry analysis 
3.4.1. Ki-67 
3.4.1.1. Descriptive analysis of Ki-67 positive proliferative cells 
Ki-67, the se lected intrinsic marker for proliferative cells in this experiment, was positively 
labelled in neural differenti ated cells, from both phenotyped DPSCs and SHEDs. The 
stained cells displayed crisp to dark brown nuclei and their distribution within the culture 
flasks appeared to vary according to the period of incubation. At day 7, the Ki-67 positive 
proliferative cells were observed in a greater number, in both populations and in 
accordance to the higher rate of self-renewal at that designated time. At day 21 , the Ki-67 
labelled cells were visualised as scattered throughout the cell cultures and this was due to 
the low replication rate of the more mature cells detected at that point of incubation (Fig. 
25). 
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Figure 25: Representative photomicrograph of Ki-67 positive proliferative cells exhibited 
in both deciduous and permanent teeth at day 21. 
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3.4.1.2. Quantitative analysis of Ki-67 positive proliferative cells 
3.4.1.2.1. Percentage of Ki-67 positive proliferative cells 
The descriptive analysis included the continuous variables of the percentage of Ki-67 
positive proliferative cells, in both deciduous and permanent teeth , and was analysed and 
summarised by using the mean , standard deviation, median and interqual1ile range, and their 
distribution was illustrated with bar column graphs. Furthermore, the relationship between 
the percentages of Ki-67 positive proliferative cells at days 7, 14 and 21 was determined by 
a one-way repeated analysis of variance (ANOVA). 
The mean indices of the percentage of viable cells for both deciduous and permanent teeth 
were calculated at days 7, 14 and 21 and they are shown in Tables 7 and 8. 
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Table 7: Mean indices of the percentage of positive proliferative Ki-67 cells in deciduous 
teeth, at days 7, 14 and 21. 
Day Number of teeth Mean percentage of Ki-67+ (SD) Range 
Day 7 30 68.1 (5.3) 56-78% 
Day 14 30 55.0 (7.0) 39-67% 
Day21 30 43.5 (6.9) 28-64% 
Table 8: Mean indices of the percentage of positive proliferative Ki-67 cells in permanent 
teeth, at days 7, 14 and 21. 
Day Number of teeth Mean percentage of Ki-67+ (SD) Range 
Day 7 30 69.3 (3.7) 59-78% 
Day 14 30 55.4 (5.8) 44-66% 
Day 21 30 44.5 (7.3) 31-62% 
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Figure 26: Representative histograms of the percentage ofKI-67 positive proliferative cells for 
deciduous (A) and permanent (B) teeth at day 7, at day 14 for deciduous (C) and permanent (D) 
teeth and day 21 for deciduous (E) and permanent (F). 
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3.4.1.2.2. Comparative analysis of positive proliferative Ki-67 cells 
For each designated time point, the mean percentage ofKi-67 positive proliferative cells 
were statistically compared using an analysis of variance (ANOVA) and they were all 
significantly different to each other (p<O.OOl), as it is illustrated in Fig. 27. 
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Figure 27: Representative graph of the comparison of the percentage of positive proliferative Ki-67 
cells at days 7, 14 and 21 , in deciduous (A) and permanent (8) teeth. 
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3.4.2. Doublecortin (DCX) 
3.4.2.1. Descriptive analysis of positive DCX labelled cells 
Characterised SHEDs and DPSCs cultured in the neuroinductive medium both exhibited 
cells that were positively labelled for doublecortin . Most of the differentiated neuronal 
cells exhibited stellate shaped morphology with growing cell processes. Although the 
expression was rather weak in all samples, it became clearly detectable from day 7 and 
progressively decreasing with the incubation time as the newly differentiated neurogenic 
cells were undergoing maturation (Fig. 28). 
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DOUBLECORTIN EXPRESSION 
Figure 28: Representative photomicrograph of DCX positive proliferative cells exhibited in both 
deciduous and permanent teeth at day 7 (x 100). 
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3.4.2.2. Quantitative analysis of positive DCX labelled cells 
The descriptive analysis inc luded the continuous variables of the percentage of DCX 
labelled cells. positive proliferative cells, in both deciduous and permanent teeth, and was 
analysed and summarised by using the mean, standard deviation , median and interquartile 
range, and their di stribution was illustrated with bar column graphs. Furthermore, the 
relationsh ip between the percentages of DCX labelled cells at days 7, 14 and 21 was 
determined by a one-way repeated analysis of variance (ANOVA). 
The mean indices of the percentage of viab le cells for both deciduous and permanent teeth 
were calculated at days 7, 14 and 21 and they are shown in Tables 9 and 10. 
Table 9: Mean indices of the percentage ofDCX+ labelled cells in deciduous teeth at days 
7, 14 and 21. 
Day Number of teeth Mean percentage of DCX+ cells (SD) Range 
Day 7 30 51.2 (9.0) 42-61% 
Day 14 30 50.3 (8.9) 42-87% 
Day 21 30 24.7 (6 .9) 17-52% 
Table 10: Mean indices of the percentage of DCX+ labelled cells in permanent teeth at 
days 7, 14 and 21. 
Day Number ofteeth Mean percentage of DCX+ cells (SD) Range 
Day 7 30 53.3 (8.1 ) 42-76% 
Day 14 30 49.8 (10.5) 42-78% 
Day 21 30 25.6 (7.0) 17-54% 
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Figure 29: Representative hi stograms of the percentage of DCX+ labelled cells at day 7 for deciduous 
(A) and permanent (8 ) teeth, day 14 for deciduous (C) and perma nent (D) teeth and day 21 for 
deciduous (E) and permanent (F) teeth. 
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For each designated time point, the mean percentage of viable neuronal differentiated cells 
were statistically compared using an analysis of variance (ANOVA) and they were all 
significantly different to each other (p<0.00 1), as it is illustrated in Fig. 30. 
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Figure 30: Representative graph of the comparison of the percentage of DCX+ labelled cells at days 
7, 14 and 21, in deciduous (A) and permanent (8) teeth. 
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3.4.3. Nestin 
3.4.3.1. Descriptive analysis positive nestin labelled cells 
Characterised SHEDs and DPSCs cultured in the neuroinductive medium both exhibited 
nestin positive labelled cells. Most of the differentiated neuronal cells exhibited stellate 
shaped morphology with growing dendritic processes. The expression of nestin , always 
exhibited in all samples, was opposite to that of doubiec0l1in during the incubation period: 
it appeared as brown stains of varying size in the cells. It also became clearly detectable 
from day 7 and progressively increased as the newly differentiated neurogenic cells were 
undergoing maturation at day 21 (Fig. 31). 
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NESTIN EXPRESSION 
Figure 31: Representative photomicrograph of nestin positive cells exhibited in both 
deciduous and permanent teeth at day 21 (x 400). The brown and rounded stains are 
demonstrated as the cells are gradually reaching maturation. 
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3.4.3.2. Quantitative analysis of positive nestin labelled cells 
3.4.3.2.1. Percentage of positive nestin labelled cells 
The descriptive analysis included the continuous variables of the percentage of nest in. 
positive labelled cells, in both deciduous and permanent teeth , and was analysed and 
summarised by using the mean, standard deviation , median and interqual1ile range, and 
their distribution was illustrated with bar column graphs. Furthermore, the relationship 
between the percentages of nestin positive labelled cells at days 7, 14 and 21 was 
determined by a one-way repeated analysis of variance (ANOvA). 
The mean indices ofthe percentage of viable cells for both deciduous and permanent teeth 
were calculated at days 7, 14 and 21 and they are shown in Tables 11 and 12. 
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Table 11: Mean indices of the percentage of positive nestin labelled ce ll s in deciduous 
teeth at days 7, 14 and 2 1. 
Day Number of teeth Mean percentage of nestin+ cells Range 
(SD) 
Day 7 30 22.2 (4.8) 12-34% 
Day 14 30 27.2 (6.4) 24-46% 
Day 21 30 32.3 (7 .1 ) 26-56% 
Table 12: Mean indices of the percentage of positive nestin labelled cells in permanent 
teeth at days 7, 14 and 21 . 
Day Number of teeth Mean percentage of nestin+ cells Range 
(SD) 
Day 7 30 22.4 (4.6) 16-35% 
Day 14 30 27.5 (6 .1 ) 21-45% 
Day 21 30 32.8 (5 .7) 28-52% 
81 
'" 
A 
'0 -
JO -
E 
~ 
If 
" 
' 0 -1 
0 , rf 
, 
" 
C 
JO 
E 
~ 
8: 
20 r-
" 
0 
, 
E 
60 -
f-
CD ~ 
25 50 
Percemage_Neslr"_D7 
r-
tdJ 
T -
" 
50 
Percel'llage_ N .. st lO _01A 
[ ~.D 
25 
" 
~ 
75 
,. 
" 
r· 
75 
"1 
B 
30 ~ 
~ ,, ~ 
,, -1 
0 
"0 0 
" I D 
30 1 
i 
~ 
" 1 
" 
T 0 1 
10' 0 
60 F 
' 0 
o ~ 
100 
.. ... = 
[ 
r-
_ ... 
-
Jb 
" " Percent~!_N!5t in_D7 
-
dJ 
" " P9l c9n1~e_He5tin_Dl • 
... --~ ..... _ .............. . 
25 
" P arcenlO1g9_N9shnJJ21 
" 
7S 
Figure 31: Representative histograms of the percentage of nestin positive labelled cells at day 7 for 
deciduous (A) and permanent (B) teeth, day 14 for deciduous (C) and permanent (D) and day 21 for 
deciduous (E) and permanent (F) teeth. 
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3.4.3.2. Comparative analysis of positive nestin labelled cells 
For each designated time point and in the two populations, the mean percentage of nestin 
positive cells and DCX positive cells were stati stically compared using an analysis of 
variance (AN OVA) and they were all significantly different to each other (p<O.OOI), as it 
is illustrated in Fig. 33. 
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Figure 33: Representative graphs of the comparison of the percentage of nestin positive cells at days 
7, 14 and 21 for deciduous (A) and permanent (B) teeth. 
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85 
CHAPTER 4 
DISCUSSION 
Since the discovery of mesenchymal stem cells, various studies have provided evidence of 
their ability of continuous self-renewal and their differentiation into several specialised cell 
lineages. They have been successfully isolated from various adult tissues and used in 
regenerative medicine, thus paving the way for stem cell biology as a research field 
(Caplan et al. 199 I). Human dental stem cells lately discovered in the teeth and their 
supportive tissues have singularised a unique pool of mesenchymal stem cells, easily 
isolated in a non-traumatic manner, thus abolishing some highly contentious ethical and 
clinical debate (Gronthos et al. 2002). 
4.1. Statement of the principal findings 
The present study has provided, in a South African cohort, descriptive and quantitative 
evidence ofthe neurogenic potential and differentiation ofthe dental stem cells identified 
in the pulp tissue of permanent and deciduous teeth namely, dental pulp stem cells 
(OPSCs) and stem cells ofthe human exfoliated deciduous teeth (SHEDs). These results, 
accomplished through a combination of cell culture, flow cytometry, neural induction and 
immunocytochemistry analysis, have granted conclusive evidence of the neurogenic 
potential of these two populations when cultured in the appropriate conditions. 
4.2. Cell culture findings 
The self-renewal potential of culture-expanded OPSCs and SHEDs, under the standard in 
vitro differentiating conditions, is well documented and has firstly been demonstrated by 
Gronthos et al. (2000) and Miura et al. (2003) respectively. One of the set criteria 
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proposed by the Mesenchymal and Tissue Stem Cell Committee of the International 
Society for Cellular Therapy (ISCT) to define human MSC for both laboratory-based 
scientific investigations as well as pre-clinical studies, and regardless of their tissue of 
origin, is their adherence to culture flasks (Dominici et af. 2006). 
The findings in this study showed that cell proliferation was successful in both populations, 
with the first sign of cell renewal and cell adherence noted after one day and three days of 
culture respectively. In each population, the mean percentages of viable celis, at each 
designated time point, were all statistically significantly different to each other (p<O.OOO I). 
On the other hand, there was no statistically significant difference in comparative indices 
of viable cells between the deciduous and permanent groups. The sample size of 30 
deciduous and permanent teeth was sufficient for descriptive analysis and paired 
comparison ofthe results obtained at different incubation times. The relationship between 
results at days 7, 14 and 21 for indices of viable cells, determined by a one-way repeated 
measures ANOV A test, was in accordance with previous studies reporting no significant 
difference (p<O.OOOI) in cellular proliferation between the two populations (Wang et al. 
2012). 
At day one, both SHEDs and DPSCs exhibited the same rounded and spherical 
morphology that has been well published, and they were still floating in the culture 
medium (Gronthos et al. 2000; Miura et al. 2003). From day 3, colony forming units of 
fibroblast-like cells (CFU-F) were discernible in the two populations, as reported by the 
latter researchers and Morszcek et al. in 2005. In addition, a significant increase in cell 
proliferation and percentage of viable cells in the culture medium, analysed at 7-days 
intervals was observed with prolonged incubation (p<O.OOO I). This was similar to the 
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early findings of Friedenstein et al. (1976) on mesenchymal stem cells cultured in vitro: he 
reported that the most tightly adherent cells in the flasks were spindled-shaped and 
aggregated in foci of two to four cells. These cells were initially inactive for 2 to 4 days, 
after which they began to rapidly multiply (Frieden stein et al. 1976). From day 7, the first 
enumeration of cells was possible with the first passage of the cells with a frequency of 
approximately I :376. This value was in accordance with the frequency of cells (1 :400) 
obtained by Gronthos et al. (2000) in their experiment on dental pulp stem cells. 
Cell culture results in this present investigation correlate extremely favourably with most 
published studies. Proliferative cells in the two populations were morphologically similar; 
in addition, the expanded cells were almost indistinguishable when the phenotype 
displayed in the two populations was observed, as reported by Wang et al. (2012). 
Furthermore, they assumed the typical spindle-shaped appearance of mesenchymal stem 
cells showing cell processes. They all exhibited heterogeneity in size and they all showed 
definite signs of cell division as indicated by their round or oval nuclei with multiple 
nucleoli. These morphological characteristics were analogous to the ones observed in 
mesenchymal stem cells obtained from the bone marrow (Huang et al. 2009). Similarly, 
the detection of cell semi-con fluency and confluency at day 14 and 21 respectively in the 
two populations cultures was also equivalent to the observations of Gronthos et al. (2000), 
Huang et al. (2009) and Miura et aI., (2003). Moreover, Gronthos et al. (2000) attributed 
the high rate of cell replication at day 21 to the several cell culture promoting supplements 
in the media. 
Manas et al. (1998) examined the morphology, phenotype and in vitro functions of 
mesenchymal stem cells isolated from bone marrow samples. They noted that from 
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passage 1 corresponding to day 14 of incubation in their study, the primary cultures 
consisted of a heterogeneous population. They observed the co-existence of 
haematopoietic stem cells as well as the typical spindle-shaped mesenchymal stem cells 
(Manas et af. 1998). The former was indicated by several accumulations of cobblestone 
areas formation characteristic of haematopoietic stem cells. The authors concluded that a 
small percentage of the latter persisted in expanded culture of mesenchymal stem cells. 
This data then demonstrated that, in long-term culture assays, mesenchymal stem cells had 
the ability to support haematopoietic differentiation in vitro (Manas et af. 1998). In the 
present study, very few rounded and viable cells were also noted and remained scattered in 
the culture flasks after days 7 (passage 1) and 14 (passage 2). However, these cells, not 
included in the study objectives, were not investigated any further. It is then recommended 
that their supplementary analysis could perhaps be included in future projects. 
4.3. Flow cytometry observations 
In the present study, the findings of the flow cytometric experiment demonstrated that cells 
from both tooth type were expressing CD29, CD44, CD90 and COlO5, with a 
predominance of C029 in deciduous teeth and C044 in the permanent teeth samples. 
There was a statistically significant difference in the C029+ and C044+ indices observed in 
permanent and deciduous teeth respectively (p<O.OOOl). Furthermore, CD90 and COlO5 
were also expressed with a higher display ofCD90 in both popUlations (58.6% and 59.5% 
in deciduous and permanent teeth respectively) and a lower detection of CD 105 (30.7% 
and 29.8% in deciduous and permanent teeth respectively). In addition, the CD14 and 
CD45 used for the negative selection in the gating strategy were not exhibited on the cell 
surface, except in the small percentage of contaminated CD29+ and C044+ cells which 
showed a slight percentage ofCD14- cells. As C014 is a marker that primarily 
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discriminates monocytes and macrophages from mesenchymal stem cells, this expression 
was probably attributed to the large size of the former cells acquired and registered in the 
forward scatter. 
The presence of CD29+ and CD44+ cells, supplemented by CD90+, CD 105+, CD 14- and 
CD4S- cells was positively identified in this experiment, thus confirming the phenotype of 
the isolated pulp tissue cells from deciduous and permanent teeth as dental stem cells. 
These results were in accordance with the findings reported by Tsai et at. (2004) who 
isolated mesenchymal stem cells from amniotic fluid obtained by second-trimester 
amniocentesis. The cell cultures were characterised from passage 8 and were analysed for 
the following surface antigens: COlO, COil, CDI4, CD34, CD90, CDIOS, CDl17 and 
HLA-A, B, C. This was the first identification of the positive expression ofCD29 and 
CD44, the low positive expression of CD90 and CD I 05 and the lack of expression of 
CDI4, in a pool of pluripotent mesenchymal stem cells. The early antigenic expression of 
CD73 demonstrated by Tsai et al. (2004) is an essential characteristic that defines 
mesenchymal stem cells. CD73 is an adhesion molecule that is thought be a signal 
transduction activator during the interaction of the mesenchymal stem cells with the rest of 
the stromal environment component (Barry et at. 2004). Although Tsai conducted his 
study in a foetal tissue, it later appeared to follow the general rules of positive and negative 
markers, as a minimal criterion of expression for mesenchymal stem cells therapy 
(Dominici et at., 2006). This also corresponded to the results ofYu et at. (2010) and 
Orciani et at. (20 10) who confirmed this phenotype in mesenchymal stem cells from 
various sources. Both authors stated the low expression of CD 105 and the absence of 
CDI4 and CD4S cell surface markers. 
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The surface antigen profile established in the culture-expanded cells was equivalent to the 
observations of Gronthos et at. (2006) who investigated the markers expressed in isolated 
adult stem cells of dental origin. In his analysis carried out in both deciduous and 
permanent teeth, the most expressed putative stem cell marker was STRO-I, a trypsin-
resistant cell-surface antigen used to isolate and purify bone marrow stromal cells. This 
was followed by the expression ofCD29 and CD44, as well as CD146, a perivascular stem 
cell marker. The expression ofCDI46 in a population of mesenchymal stem cells created 
much interest as it suggested that dental stem cells originated from the bone marrow 
perivascular niche (McCulloch et al. 1995; Bianco et al. 2001). It was also demonstrated 
that low expression of CD 146 indicated the presence of unipotent mesenchymal stem cells 
with a low cloning efficiency (McCulloch et al. 1995; Bianco et al. 200 I). Furthermore, as 
CD146 is a marker related to the regulation ofhaematopoiesis, Gronthos' conclusions 
corroborated the findings of Manas et al. (1998) describing the persistent detection of 
cobblestone-like haematopoietic stem cells in mesenchymal stem cells assays. 
Evidence of the co-existence of a small percentage of haematopoietic stem cells with 
mesenchymal stem cells has also been provided by Okolicsanyi et al. (2015). Human 
mesenchymal stem cells isolated from the iliac crest of five different healthy donors and 
commercially available were culture-expanded, for a period of approximately 60 days. 
They established that, even after 20 enzymatic passages, the incubated cells retained their 
three mesenchymal lineage potentials (chondrogenic, adipogenic and osteogenic) as well 
as their neural potential. In addition, the expression of cell surface markers was examined 
and the generated cells consistently exhibited the positive low expression of the 
haematopoietic stem cell marker CD45. However, this low manifestation ofCD45 did not 
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alter the expression of the other known mesenchymal stem cell markers (Okolicsanyi et al., 
2015). 
4.4. Neural differentiation report 
The ability of all five types of dental stem cells to differentiate into various specialised cell 
lineages, when cultured in the appropriate environment, is well documented (Gronthos et 
af. 2000; Miura et af. 2003; Seo et al. 2004; Morszeck et al. 2005; Sonoyama et af. 2008; 
Huang et af. 2009). However, the majority of the studies have particularly targeted their 
odontoblast-like and osteogenic differentiation potential for their further use in tooth 
mineralisation and repair (Gronthos et al. 2000; Laino et al. 2005; Huang et al. 2009). 
Recently, a few studies centred on the neurogenic phenotype of both SHEDs and DPSCs 
(Miura et af. 2003; Gronthos et af. 2009; Gervois et af. 2014), have successfully shown 
that they offer a reliable alternative source of mesenchymal stem cells as they can produce 
potential neurons and functional neurons in vitro (Arthur et af. 2008; Gervois et af. 2014;). 
Gronthos et al. (2000) heralded that the multipotent stem cells of the pulp of permanent 
teeth were able to express neural markers after their transplantation into mice. Three years 
later, Miura et al. (2003) described the differentiation of SHEDs into neural cells and 
established their persistent display of neuronal and glial cell markers after their in vivo 
transplantation into the dentate gyrus of immunocompromised mice. 
Dental stem cells originate from the neural crest derived ectomesenchyme (Nanci 2008; 
Moore 2013). The dorsolateral migration of the neural crest cells into the developing tooth 
during odontogenesis suggest that dental stem cells are capacitated to differentiate into 
neurogenic cells (Arthur et al. 2008; Ernst et a1.2009; Le Douarin et al.2012). This 
hypothesis has been demonstrated in several studies (Bianco et af. 2001) and dental stem 
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cells have now been progressively used for tissue repair and regeneration in 
neurodegenerative diseases (Sakai et al. 2012). Moreover, Nosrat et al. (1998) conducted 
neural differentiation experiments in the dental pulp of rats and demonstrated the 
production of neurotrophic factors by DPSCs in vitro. They further culture-expanded the 
neural differentiated DPSCs with embryonic neurons and found the viability of the latter 
were actually promoted by DPSCs (Nosrat et al. 2004). 
In the present study, DPSCS and SHEDs were incubated in 6-well plates at a concentration 
of2xl03 cells per ml of the neuroinductive medium (Gronthos et al.2009; Gervois et al. 
2014). Our results showed that cell differentiation was successful in both populations, 
with the first sign of floating neurospheres indicative of neural differentiation observed at 
early stages. As differentiation and maturation proceeded until day 21, the cells were 
acquiring a different elongated morphology with cytoplasmic extensions, typical of neural 
cells. The same period of differentiation was noted in the work of Pittenger et al. (1999), 
who investigated the multilineage potential of adult human mesenchymal stem cells. He 
demonstrated that after 3 weeks of incubation in a lineage-specific medium, culture-
expanded cells were highly exhibiting the phenotype of the selected lineage-specific cell 
types. These results were also reported by Ernst and Morszeck (2009) who studied the 
neurogenic potential of murine dental follicle stem cells. They showed the morphological 
changes undergone by the cells cultured in neurogenic medium: after the appearance of 
neutrospheres at the beginning of the cultivation, differentiated cells exhibited a flattened 
shape with dendritic extensions from day 7 of expansion in a neuroinductive medium 
(Ernst et al. 2009). Furthermore, these findings were similar to those of Gervois et al. 
(2015) who also reported the two-step process in the acquisition of neuronal morphology 
during the differentiation process. At early stages the induced DPSCs cells were 
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transformed into free floating neurospheres while in the late stage of differentiation, cells 
that grew out of the neurospheres were characterised as elongated cells with multiple 
cytoplasm ic extensions. Okol icsanyi et al. (2015) in their long-term culture of 
commercially available mesenchymal stem cells also reported the consistent formation of 
neurospheres in the initial phase of neural differentiation. This was then followed by the 
appearance of neural cells displaying a fibroblastic phenotype, even after an extended in 
vitro expansion corresponding to 20 enzymatic passages (Okolicsanyi et al. 2015). 
4.5. Immunocytochemistry findings 
The findings of this immunocytochemistry analysis ascertained the proliferation of newly 
differentiated neuronal cells through the Ki-67 positive proliferative cells and also 
established the persistence of the neural lineage throughout the incubation period with 
doublecortin and nestin immunoreactity. 
4.5.1. Ki-67 
One of the defining criteria of stem cells is their ability to self-regenerate and undergo 
multiple cycles of cell division (Kumar et al. 20l3). Cell proliferation is characterised by 
DNA replication and mitosis occurring during the cell cycle (Kumar et al. 20l3). A 
number of growth factors stimulate cells to the transition from cell quiescent phase into 
cell cycle division phase (Kumar et al. 20l3). The intrinsic proliferative capacity of cells 
can be measured by indices of proliferation factors such as Ki-67 (Kumar et al. 20l3). 
SHEDs and DPSCs have shown in previous studies, a significant proliferation rate and 
differentiation potential into many functional cell types (Gronthos et al. 2000; Miura et al. 
2003; Sakai et al. 2012). 
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The results of this present experiment revealed, in both deciduous and permanent teeth, the 
presence of Ki-67 positive proliferative cells following their exposure to a neuroinductive 
medium. SHEDs and DPSCs proliferation rates were assessed at days 7, 14 and 21 and Ki-
67 stained cells were predominant at the early stages of incubation. At day 7, the cultures 
of neural differentiated cells comprised small clusters of cells arranged into neurospheres, 
and rapidly proliferating (68.1 %). However, from day 14, the cells exhibited an elongated 
and increased size, accompanied by a deceleration in their multiplication values. In each 
population, the mean percentages of Ki-67 positive proliferative cells, at each designated 
time point, were all statistically significantly different to each other (p<O.OOO 1). On the 
other hand, there was no statistically significant difference in comparative indices of Ki-67 
positive proliferative cells between the deciduous and permanent groups. 
The findings in this study were in accordance with the reports of Gronthos et al. (2000) 
and Miura et al. (2003) who studied the proliferative activities ofDPSCs and SHEDs 
respectively. In both populations, the presence of Ki-67 nuclear labelling in the early 
stages of cell differentiation was emphasised. Moreover, the researchers observed that the 
growth rate of both cells exhibited a mild decrease after a prolonged incubation period. 
Seo et al. (2004) then Coura et al. (2008) made the same conclusion in their experiments 
on another category of dental stem cells isolated from the periodontal ligament. In 
addition, they also noted that the areas of proliferative activity were in close proximity to 
the developing blood vessels in stem cell niches, again suggesting the perivascular origin 
of dental stem cells (Seo et al. 2004; Coura et al. 2008). It is worthwhile noting that the 
decreased values in time ofKi-67 indices were contradictory to the recent work of 
Okolicsanyi et al. (2015) who were able to demonstrate a high growth rate as well as a 
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maintained differentiation potential in long-term culture-expanded mesenchymal stem 
cells. 
4.5.2. Doublecortin 
The findings of the immunocytochemistry analysis of double cortin (OCX) in this present 
study established the differentiation potential of SHEDs and DPSCs into immature 
neurons. To date, insufficient studies reporting the expression of DCX in neurogenic cells 
of dental stem cells origin have been undertaken. On the other hand, Blll-tubulin, a protein 
almost exclusively active in immature neurons has been studied (Bohlen et at. 2007; 
Gunewardene et al. 2014). 
Following the confirmation of the proliferative activity in the neuroinduced cultures, the 
expression of doublecortin (DCX) was investigated. In both SHEDs and DPSCs, a 
generally weak expression of DCX was observed. In addition, the estimated levels of 
DCX labelled cells were decreased with the incubation period. DCX levels of SHEDs and 
DPSCs were assessed at days 7, 14 and 21 and DCX stained cells were more discernible at 
the early stages of incubation. At day 7, the cultures of neural differentiated cells 
comprised DCX labelled cells scattered in the neurogenic medium and from day 14, there 
was a clear decrease in their number. In each population, the mean percentages of DCX 
positive labelled cells, at each designated time point, were all statistically significantly 
different to each other (p<O.OOO 1). On the other hand, there was no statistically significant 
difference in comparative indices of DC X positive labelled cells between the deciduous 
and permanent groups. 
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Sakai et af. (2012) investigated the neuroregenerative properties of SHEDs and DPCSs by 
transplanting them into a transected rat's spinal cord. Following their neurogenic 
induction, both populations co-expressed amongst other neural lineage markers, DCX, 
BlIl-tubulin and nestin. The obtained data showed that secretions of DC X and BIII-tubulin 
were predominant in the early stages of neural differentiation suggesting the higher 
percentage of immature neurons at that designated time (Sakai et al. 2012). The 
neuroregenerative properties of SHEDs and DPCSs were later evaluated by transplanting 
them into a transected rat's spinal cord. The findings revealed that during the acute phase 
of spinal cord injury, both SHEDs and DPSCs significantly improved the recovery of the 
locomotor function (Sakai et af. 2012). 
The results in this present research were similar to that of Tamaki et al. (2013) who 
analysed the neurogenic induction of human dental stem cells and bone marrow 
mesenchymal stem cells in vitro. The researchers confirmed the endogenous production of 
BIII-tubulin in the early stages of neural differentiation. From day 7, they noted that the 
cells exhibited a more neuron-like multipolar appearance (Tamaki et aI., 2013). 
Furthermore, in the dental stem cells group, the examination of the control cells cultured in 
the standard clonogenic growth medium revealed the continuous expression of BIIl-
tubulin. They therefore concluded that, because of the contribution of neural crest cells 
during tooth development (Le Douarin et al., 2012), dental stem cells had the intrinsic 
ability to differentiate into neuronal cells and neural maturation was then accomplished 
through the neuroinductive medium (Tamaki et aI., 2013). 
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4.5.3. Nestin 
The findings of the immunocytochemistry analysis of nest in in this present experiment 
established the differentiation competency of SHEDs and DPSCs into mature neurons. 
The expression of nest in was evaluated in both populations of SHEDs and DPSCS and it 
exhibited varying patterns with the period of incubation. Nestin levels in SHEDs and 
DPSCs were assessed at days 7, 14 and 21 and nestin stained cells were predominant at the 
late stages of incubation. At day 7, the cultures of neural differentiated cells comprised 
nestin labelled cells scattered in the neurogenic medium and from day 14, there was an 
increase in their number. In each population, the mean percentages of nestin 
immunoreactive cells, at each designated time point, were all statistically significantly 
different to each other (p<O.OOO 1). On the other hand, there was no statistically significant 
difference in comparative indices of nestin positive cells between the deciduous and 
permanent groups. 
This result was in accordance with several reports in the literature showing the standard 
expression of nestin in dental stem cells, after the stage of neurospheres and at late stages 
of the incubation period (Gronthos et al. 2002 and 2006; Miura et al. 2003; Morszeck et al. 
2005; Sakai et al. 2012). Gronthos et al. (2002,2006) and Miura et al. (2003) detected the 
expression of nestin in DPSCs and SHEDS neurogenic cultures respectively, from day 14 
of neural differentiation. Morszeck et al. (2005) reported the same observations in dental 
follicle stem cell neurogenic cultures and the high numbers of nestin positive cells was 
emphasised. This was attributed to the embryonic nature pertaining to the dental follicle 
and still maintained in the impacted third molar teeth. 
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However, these results were not similar to the findings of About et af. (2000) who explored 
the nestin expression in a sample of embryonic and adult human teeth. Active secretion of 
nestin was demonstrated in dental pulp tissue cultures of both embryonic and permanent 
teeth at all stages of development. In the embryonic samples. nestin labelled cells were 
shown in the developing odontoblasts from the bell stage of tooth development. In the 
developing third molar of young adult patients, nestin expression was also displayed in the 
odontoblasts and the authors attributed this immunoreactivity to the neural crest-derived 
nature of the odontogenic ectomesenchyme. They thus recommended the use ofNeuN, a 
soluble nuclear protein commonly used for as a biomarker for most neuronal cells (Mullen 
et af. 1992), for the identification of mature neuronal cells in dental tissues (About et af., 
2000). 
The latter results were also confirmed by Kerkis et af. (2007) who analysed cells isolated 
from deciduous pulp tissue samples. These cells were termed immature dental pulp stem 
cells (IDPSCs) as they expressed several embryonic stem cell markers. The spontaneous 
expression of neuronal markers (nestin and BIll -tubulin) was noted in both the 
experimental cells incubated in the neurogenic medium and the control group cultured in 
the standard clonogenic medium. Furthermore, nestin positive cells were as numerous as 
BIII-tubulin labelled cells during the entire differentiation process. The authors then 
suggested that IDPSCs could perhaps represent multipotent precursors of both SHEDs and 
DPSCs, however, recommended further studies in order to confirm their hypothesis. 
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CONCLUSION 
5.1. Cell culture 
CHAPTERS 
Cells isolated from the pulp of extracted deciduous and permanent teeth are highly 
proliferative, adherent in cell culture and they remain vital after a 3 weeks incubation 
period. The co-existence of haematopoietic stem cells with mesenchymal stem cells, 
although noted, has not been investigated further and this observation can be recommended 
for further studies. 
5.2. Flow cytometry 
The culture-expanded cells from the pulp tissue of deciduous and permanent teeth display 
the phenotypic cell surface markers described by the International Society of Cellular 
Therapy to characterise as mesenchymal stem cells: they were identified by various 
positive (CD29, CD44, CD90 and CDI OS) and negative mesenchymal stem cell markers 
(CD14 and CD4S). However, in both populations, the low expression ofCD4S+ cells 
observed in both populations again eludes to the expansion ofhaematopoietic stem cells in 
cultures of mesenchymal stem cells. This should be further examined in future 
experiments. 
5.3. Neural differentiation 
Characterised stem cells isolated from the human deciduous teeth and dental pulp stem 
cells exhibit the potential of self-renewal and differentiation in neuronal lineage. However, 
our study, restricted to an incubation period of three weeks, did not evaluate this 
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competency for a longer timeframe. A long term neural differentiation study could be 
envisaged in future work. 
5.4. Immunocytochemistry 
Ki-67 positive proliferative cells as well as doublecortin and nestin labelled cells in the 
neuroinduced SHEDs and DPSCs medium has been confirmed. In addition, an impaired 
proliferation rate has been noted after a prolonged culture period. Further investigation 
could perhaps intercept the exact time of cell incubation when this proliferation ceases. 
Furthermore, nestin expression throughout the life cycle of both the deciduous and 
permanent teeth, due to the neurocrestal origin of the odontogenic ectomesenchyme, has 
been reported. Future studies could perhaps focus on the expression ofNeuN, a neuronal 
specific nuclear marker observed in most neuronal cell types in human. Finally, in vivo 
experiments in laboratory animals could also be undertaken in order to investigate the 
functional capacity of these neuronal differentiated cells 
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APPENDIX B: Cell count using a haemocytometer chamber 
The culture-expanded cells from a confluent culture in a 25m I Nunc® culture flask were 
enzymatically treated. 
• I ml of accutase-treated cells was suspended in 4ml culture of growth medium 
• 20 III of this cell suspension was mixed with an equal volume of 0.4% trypan blue 
(a dilution factor of2) and then mixed thoroughly 
• 20 III of th is suspension was then placed into the two compartments of a clean and 
dry haemocytometer chamber, using a pipette. 
• Only the viable cells (clear cells) within the five squares were counted using the 
following formula below: 
• Cells per ml = average cell count per square X dilution factor X 104 
The desired cell concentration was obtained by diluting the cell suspension. 
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APPENDIX Cl: Media 
Phosphate buffered saline (PBS) (pH 7.4) 
The following salts were added to I litre of distilled water 
Na2HP04 
NaH2P04 
NaCI 
10.9 g 
3.2 g 
9g 
The pH of the solution was adjusted to 7.4 by adding 1M NaOH, then the solution was 
autoclaved and stored at 4°C. 
Digestive solution: 
The digestive solution consisted of the following supensions: 
Co llagenase: 
Dispase: 
6 mg / ml (0.06 g /10 ml) in PBS. 
8 mg / ml (0.08 g / 10ml) in PBS. 
The abovementioned suspensions were added to a 50 ml tube, at a ratio of I: I to obtain the 
digestive solution which was stored at -20°C and warmed to 37°C before use. 
Clonogenic medium: 
Add the following reagents to 80 ml of Alpha MEM: 
FBS: 
L-glutamine: 
Stock of J3-mecaptoethanol: 
Stock ofL-ascorbic acid 2-phosphate: 
Penicillin/Streptomycin: 
20 ml ofFBS 
1 ml 
250 ~l 
I 00 ~l of (1 000 x stock) in 100 ml 
50 ~l 
The solution was mixed and then stored at 4°C. 
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APPENDIX C2: Neurogenic Media 
Neuroinductive medium A 
The following reagents were added to 100 ml ofNeurobasal A media: 
B27 Supplement: 
Basic fibroblast growth factor: 
Penicillin/Streptomycin: 
Epidermal growth factor: 
Neuroinductive medium B 
The following reagents were added to 100 ml of a solution made of 50 ml of DMEM and 
50 ml ofF12 media: 
Insulin transferrin-sodium selenite supplement: 
Basic fibroblast growth factor: 
Penicillin/Streptomycin: 
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APPENDIX D: Immunocytochemistry solutions 
Phosphate buffered saline (PBS): 
The following salts were added into 1 litre de-ionized water: 
NaCI 8.00g 
Na 2HP04 1.1Sg 
KCI 0.20g 
KH2P04 0.20g 
The pH was adjusted to 7.4 by adding 1M NaOH and the solution was then stored at 4°C. 
Tris-Buffered Saline (TBS): 
The following salts were added into 1 litre de-ionized water: 
TRIS-BASE 6.0SSg 
NaCI 8.766g 
The pH was adjusted to 7.4 by adding 1M NaOH and the solution was then stored at 4°C. 
Diaminobenzidine tetrahydrochloride (DAB) reagent: 
DAB reagent consisted ofthe following suspensions: 
7 111 of 30% H202 added to 10 ml of distilled water 
1 mg/ ml DAB was added into 10 ml PBS 
The two solutions were then mixed and filtered through a filter paper. 
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APPENDIX El: Antibodies titration (CD14) 
FACSDiva Version 6.2 
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APPENDIX E2: Antibodies titration (CD4S) 
FACSDiva Version 6.2 
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APPENDIX E3: Antibodies titration (CD29) 
FACSDiva Version 6.2 
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APPENDIX E4: Antibodies titration (CD44) 
FACSDiva Version 6.2 
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APPENDIX F: Compensation beads (experimental group) 
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$OP: Nyota 
QUID: e041ll16b-f52e-4228-938f-8b45abc2Illdb 
Population #Events %Parent 
2,491 
2,090 
49.8 
83.9 
CD29 PE Stained Control 
50 100 150 200 250 
FS C-A (x 1,000) 
Specimen Name: Compensation Controls 
Tube Name: CD29 PE Stained Control 
$OP: Nyota 
CD44 FlTC-A CD44 FlTC-A 
Mean 
4,3 42 
4,357 
Median 
4,303 
4,295 
CD29 PE Stained Control 
10:1 10 
CD29 PE-A 
GUID: cB259635-b3ge-4 7cc-b324-6bB7204 5 7 5e2 
Population #Events 
2,961 
2,766 
%Parent 
59.2 
93.4 
111 
CD29 PE-A CD29 PE-A 
Mean 
10,900 
11,050 
Median 
10,677 
10,682 
C 
::l 
o 
o 
C 
::l 
o 
o 
c: 
::> 
o 
o 
APPENDIX F: Compensation beads (control group) 
Unstained Control 
50 100 150 
FSC·A 
Unstained Control 
FACSDiva Version 6.2 
.. .. ; 
200 250 
(x 1,000) 
c: 
::> 
o 
o 
C 
::l 
o 
o 
C 
::l 
o 
o 
Unstained Control 
Unstained 
Specimen Name Compensation Controls 
Tube Name Unslainea Control 
PopulallOn 
. PI 
112 
FlTC-A FlTC·A PE·A PE-APE-Cy _ PE-C. APC-A APC-A APC-.. APC-... Horiz. HOflz . 
Mean Meaian Mean Median Mean Meaian Mean Meaian Mean Meaian Mean Median . 
8 3 4 3 0 I I 0 0 240 236 
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